| 7k9p.1.A | Uridylate-specific endoribonuclease
Room temperature structure of NSP15 Endoribonuclease from SARS CoV-2 solved using SFX. | 0.97 | 0.87 | 100.00 | 1.00 | 1-346 | X-ray | 2.60 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7k9p.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7k9p.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7k9p.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7k9p.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7k9p.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7k9p.1.B | Uridylate-specific endoribonuclease
Room temperature structure of NSP15 Endoribonuclease from SARS CoV-2 solved using SFX. | 0.97 | 0.87 | 100.00 | 1.00 | 1-346 | X-ray | 2.60 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7k9p.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7k9p.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7k9p.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7k9p.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7k9p.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7k9p.1.C | Uridylate-specific endoribonuclease
Room temperature structure of NSP15 Endoribonuclease from SARS CoV-2 solved using SFX. | 0.97 | 0.87 | 100.00 | 1.00 | 1-346 | X-ray | 2.60 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7k9p.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7k9p.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7k9p.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7k9p.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7k9p.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7k9p.1.D | Uridylate-specific endoribonuclease
Room temperature structure of NSP15 Endoribonuclease from SARS CoV-2 solved using SFX. | 0.97 | 0.88 | 100.00 | 1.00 | 1-346 | X-ray | 2.60 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7k9p.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7k9p.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7k9p.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7k9p.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7k9p.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7k9p.1.E | Uridylate-specific endoribonuclease
Room temperature structure of NSP15 Endoribonuclease from SARS CoV-2 solved using SFX. | 0.97 | 0.88 | 100.00 | 1.00 | 1-346 | X-ray | 2.60 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7k9p.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7k9p.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7k9p.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7k9p.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7k9p.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7k9p.1.F | Uridylate-specific endoribonuclease
Room temperature structure of NSP15 Endoribonuclease from SARS CoV-2 solved using SFX. | 0.97 | 0.88 | 100.00 | 1.00 | 1-346 | X-ray | 2.60 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7k9p.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7k9p.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7k9p.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7k9p.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7k9p.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s6x.1.A | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2889976755 | 0.99 | 0.89 | 100.00 | 1.00 | 1-346 | X-ray | 2.32 | homo-hexamer | 6 x WUG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s6x.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s6x.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s6x.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s6x.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s6x.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s6x.1.B | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2889976755 | 0.99 | 0.89 | 100.00 | 1.00 | 1-346 | X-ray | 2.32 | homo-hexamer | 6 x WUG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s6x.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s6x.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s6x.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s6x.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s6x.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s6x.1.C | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2889976755 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.32 | homo-hexamer | 6 x WUG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s6x.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s6x.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s6x.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s6x.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s6x.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s6x.1.D | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2889976755 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.32 | homo-hexamer | 6 x WUG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s6x.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s6x.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s6x.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s6x.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s6x.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s6x.1.E | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2889976755 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.32 | homo-hexamer | 6 x WUG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s6x.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s6x.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s6x.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s6x.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s6x.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s6x.1.F | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2889976755 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.32 | homo-hexamer | 6 x WUG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s6x.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s6x.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s6x.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s6x.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s6x.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s6y.1.A | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z56900771 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.32 | homo-hexamer | 6 x WUJ | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s6y.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s6y.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s6y.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s6y.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s6y.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s6y.1.B | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z56900771 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.32 | homo-hexamer | 6 x WUJ | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s6y.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s6y.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s6y.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s6y.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s6y.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s6y.1.C | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z56900771 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.32 | homo-hexamer | 6 x WUJ | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s6y.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s6y.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s6y.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s6y.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s6y.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s6y.1.D | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z56900771 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.32 | homo-hexamer | 6 x WUJ | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s6y.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s6y.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s6y.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s6y.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s6y.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s6y.1.E | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z56900771 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.32 | homo-hexamer | 6 x WUJ | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s6y.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s6y.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s6y.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s6y.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s6y.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s6y.1.F | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z56900771 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.32 | homo-hexamer | 6 x WUJ | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s6y.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s6y.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s6y.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s6y.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s6y.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s6z.1.A | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with PB2255187532 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.28 | homo-hexamer | 6 x WUM | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s6z.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s6z.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s6z.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s6z.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s6z.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s6z.1.B | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with PB2255187532 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.28 | homo-hexamer | 6 x WUM | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s6z.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s6z.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s6z.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s6z.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s6z.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s6z.1.C | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with PB2255187532 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.28 | homo-hexamer | 6 x WUM | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s6z.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s6z.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s6z.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s6z.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s6z.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s6z.1.D | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with PB2255187532 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.28 | homo-hexamer | 6 x WUM | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s6z.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s6z.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s6z.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s6z.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s6z.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s6z.1.E | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with PB2255187532 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.28 | homo-hexamer | 6 x WUM | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s6z.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s6z.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s6z.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s6z.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s6z.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s6z.1.F | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with PB2255187532 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.28 | homo-hexamer | 6 x WUM | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s6z.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s6z.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s6z.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s6z.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s6z.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s70.1.A | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-181428 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.33 | homo-hexamer | 3 x WUS | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s70.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s70.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s70.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s70.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s70.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s70.1.B | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-181428 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.33 | homo-hexamer | 3 x WUS | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s70.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s70.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s70.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s70.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s70.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s70.1.C | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-181428 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.33 | homo-hexamer | 3 x WUS | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s70.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s70.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s70.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s70.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s70.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s70.1.D | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-181428 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.33 | homo-hexamer | 3 x WUS | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s70.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s70.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s70.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s70.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s70.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s70.1.E | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-181428 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.33 | homo-hexamer | 3 x WUS | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s70.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s70.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s70.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s70.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s70.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s70.1.F | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-181428 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.33 | homo-hexamer | 3 x WUS | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s70.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s70.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s70.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s70.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s70.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7keg.1.A | Uridylate-specific endoribonuclease
Crystal structure from SARS-COV2 NendoU NSP15 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.90 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7keg.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7keg.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7keg.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7keg.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7keg.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7keh.1.D | Uridylate-specific endoribonuclease
Crystal structure from SARS-CoV-2 NendoU NSP15 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.59 | homo-hexamer | 6 x B3P | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7keh.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7keh.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7keh.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7keh.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7keh.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7keh.1.F | Uridylate-specific endoribonuclease
Crystal structure from SARS-CoV-2 NendoU NSP15 | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.59 | homo-hexamer | 6 x B3P | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7keh.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7keh.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7keh.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7keh.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7keh.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7keg.1.D | Uridylate-specific endoribonuclease
Crystal structure from SARS-COV2 NendoU NSP15 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.90 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7keg.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7keg.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7keg.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7keg.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7keg.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s71.1.F | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with FUZS-5 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.94 | homo-hexamer | 6 x WUV | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s71.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s71.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s71.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s71.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s71.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7keg.1.C | Uridylate-specific endoribonuclease
Crystal structure from SARS-COV2 NendoU NSP15 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.90 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7keg.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7keg.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7keg.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7keg.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7keg.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7keg.1.F | Uridylate-specific endoribonuclease
Crystal structure from SARS-COV2 NendoU NSP15 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.90 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7keg.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7keg.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7keg.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7keg.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7keg.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7keh.1.E | Uridylate-specific endoribonuclease
Crystal structure from SARS-CoV-2 NendoU NSP15 | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.59 | homo-hexamer | 6 x B3P | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7keh.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7keh.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7keh.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7keh.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7keh.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7kf4.1.C | Uridylate-specific endoribonuclease
Crystal structure from SARS-CoV-2 NendoU NSP15 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.61 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7kf4.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7kf4.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7kf4.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7kf4.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7kf4.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7kf4.1.B | Uridylate-specific endoribonuclease
Crystal structure from SARS-CoV-2 NendoU NSP15 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.61 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7kf4.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7kf4.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7kf4.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7kf4.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7kf4.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7keh.1.A | Uridylate-specific endoribonuclease
Crystal structure from SARS-CoV-2 NendoU NSP15 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.59 | homo-hexamer | 6 x B3P | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7keh.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7keh.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7keh.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7keh.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7keh.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s71.1.A | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with FUZS-5 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.94 | homo-hexamer | 6 x WUV | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s71.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s71.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s71.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s71.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s71.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7kf4.1.E | Uridylate-specific endoribonuclease
Crystal structure from SARS-CoV-2 NendoU NSP15 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.61 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7kf4.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7kf4.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7kf4.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7kf4.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7kf4.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s71.1.D | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with FUZS-5 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.94 | homo-hexamer | 6 x WUV | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s71.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s71.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s71.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s71.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s71.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7keh.1.C | Uridylate-specific endoribonuclease
Crystal structure from SARS-CoV-2 NendoU NSP15 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.59 | homo-hexamer | 6 x B3P | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7keh.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7keh.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7keh.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7keh.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7keh.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s71.1.E | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with FUZS-5 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.94 | homo-hexamer | 6 x WUV | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s71.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s71.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s71.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s71.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s71.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7keg.1.E | Uridylate-specific endoribonuclease
Crystal structure from SARS-COV2 NendoU NSP15 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.90 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7keg.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7keg.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7keg.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7keg.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7keg.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s71.1.C | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with FUZS-5 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.94 | homo-hexamer | 6 x WUV | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s71.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s71.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s71.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s71.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s71.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7keg.1.B | Uridylate-specific endoribonuclease
Crystal structure from SARS-COV2 NendoU NSP15 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.90 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7keg.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7keg.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7keg.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7keg.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7keg.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7kf4.1.A | Uridylate-specific endoribonuclease
Crystal structure from SARS-CoV-2 NendoU NSP15 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.61 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7kf4.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7kf4.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7kf4.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7kf4.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7kf4.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s71.1.B | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with FUZS-5 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.94 | homo-hexamer | 6 x WUV | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s71.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s71.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s71.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s71.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s71.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7keh.1.B | Uridylate-specific endoribonuclease
Crystal structure from SARS-CoV-2 NendoU NSP15 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.59 | homo-hexamer | 6 x B3P | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7keh.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7keh.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7keh.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7keh.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7keh.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s72.1.C | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with BBL029427 | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.51 | homo-hexamer | 3 x WUY | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s72.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s72.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s72.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s72.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s72.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s72.1.A | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with BBL029427 | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.51 | homo-hexamer | 3 x WUY | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s72.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s72.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s72.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s72.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s72.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s72.1.E | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with BBL029427 | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.51 | homo-hexamer | 3 x WUY | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s72.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s72.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s72.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s72.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s72.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s72.1.B | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with BBL029427 | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.51 | homo-hexamer | 3 x WUY | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s72.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s72.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s72.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s72.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s72.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s72.1.F | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with BBL029427 | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.51 | homo-hexamer | 3 x WUY | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s72.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s72.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s72.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s72.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s72.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5s72.1.D | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with BBL029427 | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.51 | homo-hexamer | 3 x WUY | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5s72.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5s72.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5s72.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5s72.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5s72.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sad.1.A | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z425449682 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.96 | homo-hexamer | 3 x EJW | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sad.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sad.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sad.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sad.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sad.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sad.1.B | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z425449682 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.96 | homo-hexamer | 3 x EJW | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sad.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sad.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sad.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sad.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sad.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5saa.1.E | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z319891284 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.24 | homo-hexamer | 6 x ZQD | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5saa.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5saa.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5saa.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5saa.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5saa.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa4.1.A | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z239136710 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.05 | homo-hexamer | 3 x K3A | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa4.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa4.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa4.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa4.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa4.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5saa.1.D | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z319891284 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.24 | homo-hexamer | 6 x ZQD | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5saa.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5saa.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5saa.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5saa.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5saa.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sac.1.B | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z59181945 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.03 | homo-hexamer | 3 x VWG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sac.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sac.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sac.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sac.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sac.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5saa.1.C | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z319891284 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.24 | homo-hexamer | 6 x ZQD | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5saa.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5saa.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5saa.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5saa.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5saa.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa4.1.B | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z239136710 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.05 | homo-hexamer | 3 x K3A | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa4.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa4.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa4.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa4.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa4.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5saf.1.E | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-321461 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.11 | homo-hexamer | 6 x WOY | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5saf.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5saf.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5saf.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5saf.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5saf.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sag.1.C | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-1605072 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.88 | homo-hexamer | 3 x ZQG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sag.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sag.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sag.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sag.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sag.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sae.1.B | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z3219959731 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.12 | homo-hexamer | 6 x W3G | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sae.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sae.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sae.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sae.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sae.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sah.1.F | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-100112 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.16 | homo-hexamer | 6 x ZQJ | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sah.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sah.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sah.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sah.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sah.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sai.1.B | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1424343998 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.02 | homo-hexamer | 3 x ZQM | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sai.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sai.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sai.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sai.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sai.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sah.1.D | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-100112 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.16 | homo-hexamer | 6 x ZQJ | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sah.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sah.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sah.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sah.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sah.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa7.1.F | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1673618163 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.22 | homo-hexamer | 3 x WL7 | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa7.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa7.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa7.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa7.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa7.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sai.1.A | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1424343998 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.02 | homo-hexamer | 3 x ZQM | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sai.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sai.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sai.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sai.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sai.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa5.1.D | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1530301542 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.09 | homo-hexamer | 3 x ZQA | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa5.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa5.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa5.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa5.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa5.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sah.1.B | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-100112 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.16 | homo-hexamer | 6 x ZQJ | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sah.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sah.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sah.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sah.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sah.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sab.1.E | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z31504642 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.49 | homo-hexamer | 3 x WJD | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sab.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sab.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sab.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sab.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sab.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa9.1.C | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2697514548 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.92 | homo-hexamer | 3 x GWG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa9.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa9.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa9.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa9.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa9.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sai.1.E | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1424343998 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.02 | homo-hexamer | 3 x ZQM | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sai.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sai.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sai.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sai.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sai.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sah.1.C | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-100112 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.16 | homo-hexamer | 6 x ZQJ | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sah.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sah.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sah.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sah.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sah.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sae.1.F | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z3219959731 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.12 | homo-hexamer | 6 x W3G | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sae.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sae.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sae.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sae.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sae.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5saf.1.B | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-321461 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.11 | homo-hexamer | 6 x WOY | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5saf.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5saf.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5saf.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5saf.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5saf.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sag.1.E | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-1605072 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.88 | homo-hexamer | 3 x ZQG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sag.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sag.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sag.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sag.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sag.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa5.1.A | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1530301542 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.09 | homo-hexamer | 3 x ZQA | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa5.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa5.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa5.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa5.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa5.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sab.1.A | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z31504642 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.49 | homo-hexamer | 3 x WJD | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sab.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sab.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sab.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sab.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sab.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa9.1.B | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2697514548 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.92 | homo-hexamer | 3 x GWG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa9.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa9.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa9.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa9.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa9.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sac.1.E | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z59181945 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.03 | homo-hexamer | 3 x VWG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sac.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sac.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sac.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sac.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sac.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sag.1.F | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-1605072 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.88 | homo-hexamer | 3 x ZQG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sag.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sag.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sag.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sag.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sag.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa7.1.D | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1673618163 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.22 | homo-hexamer | 3 x WL7 | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa7.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa7.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa7.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa7.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa7.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sab.1.D | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z31504642 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.49 | homo-hexamer | 3 x WJD | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sab.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sab.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sab.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sab.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sab.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5saf.1.D | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-321461 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.11 | homo-hexamer | 6 x WOY | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5saf.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5saf.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5saf.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5saf.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5saf.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa7.1.A | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1673618163 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.22 | homo-hexamer | 3 x WL7 | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa7.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa7.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa7.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa7.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa7.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sae.1.E | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z3219959731 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.12 | homo-hexamer | 6 x W3G | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sae.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sae.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sae.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sae.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sae.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sae.1.A | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z3219959731 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.12 | homo-hexamer | 6 x W3G | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sae.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sae.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sae.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sae.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sae.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5saa.1.A | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z319891284 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.24 | homo-hexamer | 6 x ZQD | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5saa.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5saa.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5saa.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5saa.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5saa.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sah.1.A | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-100112 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.16 | homo-hexamer | 6 x ZQJ | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sah.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sah.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sah.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sah.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sah.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa4.1.E | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z239136710 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.05 | homo-hexamer | 3 x K3A | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa4.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa4.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa4.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa4.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa4.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sab.1.F | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z31504642 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.49 | homo-hexamer | 3 x WJD | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sab.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sab.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sab.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sab.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sab.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa4.1.C | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z239136710 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.05 | homo-hexamer | 3 x K3A | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa4.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa4.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa4.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa4.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa4.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa9.1.D | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2697514548 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.92 | homo-hexamer | 3 x GWG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa9.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa9.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa9.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa9.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa9.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sac.1.D | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z59181945 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.03 | homo-hexamer | 3 x VWG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sac.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sac.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sac.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sac.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sac.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sab.1.B | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z31504642 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.49 | homo-hexamer | 3 x WJD | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sab.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sab.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sab.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sab.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sab.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa5.1.F | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1530301542 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.09 | homo-hexamer | 3 x ZQA | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa5.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa5.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa5.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa5.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa5.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa6.1.E | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2856434783 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.52 | homo-hexamer | 6 x O3G | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa6.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa6.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa6.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa6.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa6.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa9.1.A | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2697514548 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.92 | homo-hexamer | 3 x GWG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa9.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa9.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa9.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa9.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa9.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa9.1.F | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2697514548 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.92 | homo-hexamer | 3 x GWG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa9.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa9.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa9.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa9.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa9.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa5.1.E | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1530301542 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.09 | homo-hexamer | 3 x ZQA | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa5.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa5.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa5.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa5.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa5.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sab.1.C | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z31504642 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.49 | homo-hexamer | 3 x WJD | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sab.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sab.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sab.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sab.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sab.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sac.1.F | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z59181945 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.03 | homo-hexamer | 3 x VWG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sac.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sac.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sac.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sac.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sac.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5saf.1.C | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-321461 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.11 | homo-hexamer | 6 x WOY | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5saf.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5saf.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5saf.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5saf.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5saf.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sad.1.D | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z425449682 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.96 | homo-hexamer | 3 x EJW | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sad.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sad.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sad.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sad.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sad.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sae.1.D | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z3219959731 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.12 | homo-hexamer | 6 x W3G | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sae.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sae.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sae.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sae.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sae.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa5.1.B | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1530301542 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.09 | homo-hexamer | 3 x ZQA | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa5.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa5.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa5.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa5.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa5.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa8.1.F | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z68299550 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.30 | homo-hexamer | 6 x JOV | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa8.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa8.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa8.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa8.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa8.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa7.1.E | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1673618163 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.22 | homo-hexamer | 3 x WL7 | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa7.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa7.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa7.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa7.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa7.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sac.1.C | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z59181945 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.03 | homo-hexamer | 3 x VWG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sac.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sac.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sac.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sac.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sac.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa8.1.A | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z68299550 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.30 | homo-hexamer | 6 x JOV | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa8.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa8.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa8.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa8.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa8.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa6.1.D | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2856434783 | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.52 | homo-hexamer | 6 x O3G | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa6.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa6.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa6.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa6.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa6.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa5.1.C | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1530301542 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.09 | homo-hexamer | 3 x ZQA | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa5.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa5.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa5.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa5.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa5.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sac.1.A | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z59181945 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.03 | homo-hexamer | 3 x VWG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sac.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sac.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sac.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sac.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sac.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sag.1.B | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-1605072 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.88 | homo-hexamer | 3 x ZQG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sag.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sag.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sag.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sag.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sag.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sad.1.F | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z425449682 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.96 | homo-hexamer | 3 x EJW | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sad.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sad.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sad.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sad.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sad.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sai.1.F | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1424343998 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.02 | homo-hexamer | 3 x ZQM | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sai.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sai.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sai.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sai.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sai.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sad.1.C | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z425449682 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.96 | homo-hexamer | 3 x EJW | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sad.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sad.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sad.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sad.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sad.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa6.1.B | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2856434783 | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.52 | homo-hexamer | 6 x O3G | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa6.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa6.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa6.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa6.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa6.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5saf.1.F | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-321461 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.11 | homo-hexamer | 6 x WOY | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5saf.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5saf.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5saf.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5saf.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5saf.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sad.1.E | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z425449682 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.96 | homo-hexamer | 3 x EJW | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sad.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sad.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sad.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sad.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sad.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sae.1.C | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z3219959731 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.12 | homo-hexamer | 6 x W3G | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sae.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sae.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sae.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sae.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sae.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sai.1.D | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1424343998 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.02 | homo-hexamer | 3 x ZQM | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sai.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sai.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sai.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sai.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sai.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5saf.1.A | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-321461 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.11 | homo-hexamer | 6 x WOY | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5saf.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5saf.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5saf.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5saf.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5saf.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5saa.1.F | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z319891284 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.24 | homo-hexamer | 6 x ZQD | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5saa.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5saa.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5saa.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5saa.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5saa.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sai.1.C | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1424343998 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.02 | homo-hexamer | 3 x ZQM | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sai.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sai.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sai.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sai.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sai.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa6.1.F | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2856434783 | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.52 | homo-hexamer | 6 x O3G | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa6.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa6.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa6.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa6.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa6.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sag.1.A | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-1605072 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.88 | homo-hexamer | 3 x ZQG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sag.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sag.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sag.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sag.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sag.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa6.1.A | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2856434783 | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.52 | homo-hexamer | 6 x O3G | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa6.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa6.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa6.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa6.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa6.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa4.1.D | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z239136710 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.05 | homo-hexamer | 3 x K3A | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa4.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa4.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa4.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa4.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa4.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa7.1.B | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1673618163 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.22 | homo-hexamer | 3 x WL7 | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa7.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa7.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa7.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa7.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa7.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa8.1.C | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z68299550 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.30 | homo-hexamer | 6 x JOV | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa8.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa8.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa8.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa8.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa8.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sah.1.E | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-100112 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.16 | homo-hexamer | 6 x ZQJ | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sah.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sah.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sah.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sah.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sah.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa8.1.D | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z68299550 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.30 | homo-hexamer | 6 x JOV | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa8.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa8.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa8.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa8.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa8.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5saa.1.B | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z319891284 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.24 | homo-hexamer | 6 x ZQD | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5saa.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5saa.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5saa.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5saa.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5saa.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sag.1.D | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-1605072 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.88 | homo-hexamer | 3 x ZQG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sag.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sag.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sag.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sag.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sag.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa4.1.F | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z239136710 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.05 | homo-hexamer | 3 x K3A | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa4.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa4.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa4.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa4.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa4.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa8.1.B | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z68299550 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.30 | homo-hexamer | 6 x JOV | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa8.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa8.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa8.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa8.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa8.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa6.1.C | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2856434783 | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.52 | homo-hexamer | 6 x O3G | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa6.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa6.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa6.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa6.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa6.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa9.1.E | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2697514548 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.92 | homo-hexamer | 3 x GWG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa9.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa9.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa9.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa9.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa9.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa8.1.E | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z68299550 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.30 | homo-hexamer | 6 x JOV | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa8.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa8.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa8.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa8.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa8.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sa7.1.C | Uridylate-specific endoribonuclease
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1673618163 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.22 | homo-hexamer | 3 x WL7 | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sa7.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sa7.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sa7.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sa7.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sa7.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n7y.1.A | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with Z18197050 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.09 | homo-hexamer | 6 x RZG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n7y.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n7y.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n7y.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n7y.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n7y.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n7w.1.B | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with CSC000178569 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.42 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n7w.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n7w.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n7w.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n7w.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n7w.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n7u.1.B | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with LIZA-7 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.06 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n7u.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n7u.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n7u.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n7u.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n7u.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n7w.1.F | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with CSC000178569 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.42 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n7w.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n7w.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n7w.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n7w.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n7w.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n83.1.E | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with Z2443429438 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.91 | homo-hexamer | 21 x WNM | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n83.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n83.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n83.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n83.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n83.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n83.1.F | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with Z2443429438 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.91 | homo-hexamer | 21 x WNM | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n83.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n83.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n83.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n83.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n83.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n7u.1.F | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with LIZA-7 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.06 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n7u.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n7u.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n7u.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n7u.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n7u.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n7u.1.C | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with LIZA-7 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.06 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n7u.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n7u.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n7u.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n7u.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n7u.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n83.1.A | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with Z2443429438 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.91 | homo-hexamer | 21 x WNM | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n83.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n83.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n83.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n83.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n83.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n83.1.C | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with Z2443429438 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.91 | homo-hexamer | 21 x WNM | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n83.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n83.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n83.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n83.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n83.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n7y.1.C | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with Z18197050 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.09 | homo-hexamer | 6 x RZG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n7y.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n7y.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n7y.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n7y.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n7y.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n83.1.D | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with Z2443429438 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.91 | homo-hexamer | 21 x WNM | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n83.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n83.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n83.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n83.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n83.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n7u.1.E | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with LIZA-7 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.06 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n7u.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n7u.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n7u.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n7u.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n7u.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n7u.1.A | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with LIZA-7 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.06 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n7u.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n7u.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n7u.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n7u.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n7u.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n7y.1.D | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with Z18197050 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.09 | homo-hexamer | 6 x RZG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n7y.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n7y.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n7y.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n7y.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n7y.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n7y.1.B | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with Z18197050 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.09 | homo-hexamer | 6 x RZG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n7y.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n7y.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n7y.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n7y.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n7y.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n83.1.B | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with Z2443429438 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.91 | homo-hexamer | 21 x WNM | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n83.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n83.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n83.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n83.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n83.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n7u.1.D | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with LIZA-7 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.06 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n7u.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n7u.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n7u.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n7u.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n7u.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n7y.1.F | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with Z18197050 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.09 | homo-hexamer | 6 x RZG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n7y.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n7y.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n7y.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n7y.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n7y.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n7w.1.C | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with CSC000178569 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.42 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n7w.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n7w.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n7w.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n7w.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n7w.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n7w.1.E | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with CSC000178569 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.42 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n7w.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n7w.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n7w.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n7w.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n7w.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n7w.1.A | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with CSC000178569 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.42 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n7w.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n7w.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n7w.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n7w.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n7w.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n7w.1.D | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with CSC000178569 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.42 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n7w.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n7w.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n7w.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n7w.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n7w.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n7y.1.E | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with Z18197050 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.09 | homo-hexamer | 6 x RZG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n7y.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n7y.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n7y.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n7y.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n7y.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n7r.1.F | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with Z2472938267 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.01 | homo-hexamer | 3 x S6V | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n7r.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n7r.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n7r.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n7r.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n7r.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n7r.1.A | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with Z2472938267 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.01 | homo-hexamer | 3 x S6V | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n7r.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n7r.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n7r.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n7r.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n7r.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n7r.1.B | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with Z2472938267 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.01 | homo-hexamer | 3 x S6V | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n7r.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n7r.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n7r.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n7r.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n7r.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n7r.1.D | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with Z2472938267 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.01 | homo-hexamer | 3 x S6V | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n7r.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n7r.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n7r.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n7r.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n7r.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n7r.1.E | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with Z2472938267 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.01 | homo-hexamer | 3 x S6V | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n7r.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n7r.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n7r.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n7r.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n7r.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n7r.1.C | Uridylate-specific endoribonuclease
Crystal Structure of SARS-CoV-2 NendoU in complex with Z2472938267 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.01 | homo-hexamer | 3 x S6V | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n7r.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n7r.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n7r.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n7r.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n7r.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sbf.1.E | Uridylate-specific endoribonuclease
PanDDA analysis group deposition of ground-state model of SARS-CoV-2 NendoU | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.64 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sbf.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sbf.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sbf.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sbf.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sbf.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sbf.1.B | Uridylate-specific endoribonuclease
PanDDA analysis group deposition of ground-state model of SARS-CoV-2 NendoU | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.64 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sbf.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sbf.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sbf.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sbf.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sbf.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sbf.1.A | Uridylate-specific endoribonuclease
PanDDA analysis group deposition of ground-state model of SARS-CoV-2 NendoU | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.64 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sbf.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sbf.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sbf.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sbf.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sbf.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sbf.1.F | Uridylate-specific endoribonuclease
PanDDA analysis group deposition of ground-state model of SARS-CoV-2 NendoU | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.64 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sbf.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sbf.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sbf.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sbf.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sbf.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sbf.1.D | Uridylate-specific endoribonuclease
PanDDA analysis group deposition of ground-state model of SARS-CoV-2 NendoU | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.64 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sbf.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sbf.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sbf.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sbf.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sbf.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 5sbf.1.C | Uridylate-specific endoribonuclease
PanDDA analysis group deposition of ground-state model of SARS-CoV-2 NendoU | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.64 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5sbf.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5sbf.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 5sbf.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 5sbf.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 5sbf.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7kf4.1.D | Uridylate-specific endoribonuclease
Crystal structure from SARS-CoV-2 NendoU NSP15 | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.61 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7kf4.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7kf4.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7kf4.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7kf4.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7kf4.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7kf4.1.F | Uridylate-specific endoribonuclease
Crystal structure from SARS-CoV-2 NendoU NSP15 | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.61 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7kf4.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7kf4.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7kf4.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7kf4.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7kf4.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7rb2.1.D | Uridylate-specific endoribonuclease
Cryo-EM structure of SARS-CoV-2 NSP15 NendoU in BIS-Tris pH 6.0 | 0.97 | | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7rb2.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7rb2.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7rb2.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7rb2.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7rb2.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7rb2.1.F | Uridylate-specific endoribonuclease
Cryo-EM structure of SARS-CoV-2 NSP15 NendoU in BIS-Tris pH 6.0 | 0.97 | | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7rb2.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7rb2.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7rb2.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7rb2.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7rb2.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7rb2.1.A | Uridylate-specific endoribonuclease
Cryo-EM structure of SARS-CoV-2 NSP15 NendoU in BIS-Tris pH 6.0 | 0.97 | | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7rb2.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7rb2.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7rb2.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7rb2.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7rb2.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7rb2.1.B | Uridylate-specific endoribonuclease
Cryo-EM structure of SARS-CoV-2 NSP15 NendoU in BIS-Tris pH 6.0 | 0.97 | | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7rb2.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7rb2.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7rb2.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7rb2.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7rb2.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7rb2.1.C | Uridylate-specific endoribonuclease
Cryo-EM structure of SARS-CoV-2 NSP15 NendoU in BIS-Tris pH 6.0 | 0.97 | | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7rb2.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7rb2.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7rb2.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7rb2.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7rb2.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7rb2.1.E | Uridylate-specific endoribonuclease
Cryo-EM structure of SARS-CoV-2 NSP15 NendoU in BIS-Tris pH 6.0 | 0.97 | | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7rb2.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7rb2.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7rb2.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7rb2.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7rb2.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7rb0.1.D | Uridylate-specific endoribonuclease
Cryo-EM structure of SARS-CoV-2 NSP15 NendoU at pH 7.5 | 0.94 | | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7rb0.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7rb0.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7rb0.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7rb0.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7rb0.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7rb0.1.F | Uridylate-specific endoribonuclease
Cryo-EM structure of SARS-CoV-2 NSP15 NendoU at pH 7.5 | 0.95 | | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7rb0.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7rb0.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7rb0.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7rb0.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7rb0.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7rb0.1.C | Uridylate-specific endoribonuclease
Cryo-EM structure of SARS-CoV-2 NSP15 NendoU at pH 7.5 | 0.95 | | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7rb0.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7rb0.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7rb0.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7rb0.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7rb0.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7rb0.1.E | Uridylate-specific endoribonuclease
Cryo-EM structure of SARS-CoV-2 NSP15 NendoU at pH 7.5 | 0.94 | | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7rb0.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7rb0.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7rb0.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7rb0.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7rb0.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7rb0.1.A | Uridylate-specific endoribonuclease
Cryo-EM structure of SARS-CoV-2 NSP15 NendoU at pH 7.5 | 0.95 | | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7rb0.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7rb0.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7rb0.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7rb0.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7rb0.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7rb0.1.B | Uridylate-specific endoribonuclease
Cryo-EM structure of SARS-CoV-2 NSP15 NendoU at pH 7.5 | 0.95 | | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7rb0.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7rb0.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7rb0.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7rb0.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7rb0.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7k0r.1.A | Uridylate-specific endoribonuclease
Nucleotide bound SARS-CoV-2 Nsp15 | 0.99 | | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | 6 x U5P | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7k0r.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7k0r.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7k0r.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7k0r.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7k0r.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7k0r.1.B | Uridylate-specific endoribonuclease
Nucleotide bound SARS-CoV-2 Nsp15 | 0.99 | | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | 6 x U5P | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7k0r.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7k0r.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7k0r.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7k0r.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7k0r.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7k0r.1.C | Uridylate-specific endoribonuclease
Nucleotide bound SARS-CoV-2 Nsp15 | 0.99 | | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | 6 x U5P | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7k0r.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7k0r.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7k0r.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7k0r.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7k0r.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7k0r.1.D | Uridylate-specific endoribonuclease
Nucleotide bound SARS-CoV-2 Nsp15 | 0.99 | | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | 6 x U5P | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7k0r.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7k0r.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7k0r.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7k0r.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7k0r.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7k0r.1.E | Uridylate-specific endoribonuclease
Nucleotide bound SARS-CoV-2 Nsp15 | 0.99 | | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | 6 x U5P | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7k0r.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7k0r.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7k0r.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7k0r.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7k0r.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7k0r.1.F | Uridylate-specific endoribonuclease
Nucleotide bound SARS-CoV-2 Nsp15 | 0.99 | | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | 6 x U5P | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7k0r.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7k0r.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7k0r.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7k0r.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7k0r.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7me0.1.A | Uridylate-specific endoribonuclease
Cryo-EM structure of SARS-CoV-2 NSP15 NendoU at pH 6.0 | 0.98 | | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7me0.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7me0.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7me0.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7me0.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7me0.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7me0.1.B | Uridylate-specific endoribonuclease
Cryo-EM structure of SARS-CoV-2 NSP15 NendoU at pH 6.0 | 0.98 | | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7me0.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7me0.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7me0.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7me0.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7me0.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7me0.1.C | Uridylate-specific endoribonuclease
Cryo-EM structure of SARS-CoV-2 NSP15 NendoU at pH 6.0 | 0.98 | | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7me0.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7me0.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7me0.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7me0.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7me0.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7me0.1.D | Uridylate-specific endoribonuclease
Cryo-EM structure of SARS-CoV-2 NSP15 NendoU at pH 6.0 | 0.98 | | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7me0.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7me0.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7me0.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7me0.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7me0.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7me0.1.E | Uridylate-specific endoribonuclease
Cryo-EM structure of SARS-CoV-2 NSP15 NendoU at pH 6.0 | 0.98 | | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7me0.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7me0.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7me0.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7me0.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7me0.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7me0.1.F | Uridylate-specific endoribonuclease
Cryo-EM structure of SARS-CoV-2 NSP15 NendoU at pH 6.0 | 0.98 | | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7me0.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7me0.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7me0.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7me0.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7me0.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6xdh.1.A | Uridylate-specific endoribonuclease
Crystal Structure of NendoU (Uridylate-specific endoribonuclease, nsp15) from Betacoronavirus SARS-CoV-2 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.35 | homo-trimer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6xdh.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6xdh.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6xdh.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6xdh.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6xdh.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6xdh.1.B | Uridylate-specific endoribonuclease
Crystal Structure of NendoU (Uridylate-specific endoribonuclease, nsp15) from Betacoronavirus SARS-CoV-2 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.35 | homo-trimer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6xdh.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6xdh.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6xdh.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6xdh.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6xdh.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6xdh.1.C | Uridylate-specific endoribonuclease
Crystal Structure of NendoU (Uridylate-specific endoribonuclease, nsp15) from Betacoronavirus SARS-CoV-2 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.35 | homo-trimer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6xdh.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6xdh.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6xdh.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6xdh.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6xdh.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6xdh.2.A | Uridylate-specific endoribonuclease
Crystal Structure of NendoU (Uridylate-specific endoribonuclease, nsp15) from Betacoronavirus SARS-CoV-2 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.35 | homo-trimer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6xdh.2 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6xdh.2 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6xdh.2 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6xdh.2 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6xdh.2 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6xdh.2.B | Uridylate-specific endoribonuclease
Crystal Structure of NendoU (Uridylate-specific endoribonuclease, nsp15) from Betacoronavirus SARS-CoV-2 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.35 | homo-trimer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6xdh.2 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6xdh.2 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6xdh.2 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6xdh.2 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6xdh.2 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6xdh.2.C | Uridylate-specific endoribonuclease
Crystal Structure of NendoU (Uridylate-specific endoribonuclease, nsp15) from Betacoronavirus SARS-CoV-2 | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.35 | homo-trimer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6xdh.2 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6xdh.2 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6xdh.2 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6xdh.2 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6xdh.2 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6vww.1.F | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2. | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.20 | homo-hexamer | 3 x MG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6vww.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6vww.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6vww.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6vww.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6vww.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
✓
| 6w01.1.A | Uridylate-specific endoribonuclease
The 1.9 A Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with a Citrate | 0.99 | 0.92 | 100.00 | 1.00 | 1-346 | X-ray | 1.90 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6w01.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6w01.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6w01.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6w01.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6w01.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6w01.1.D | Uridylate-specific endoribonuclease
The 1.9 A Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with a Citrate | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.90 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6w01.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6w01.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6w01.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6w01.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6w01.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6vww.1.A | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2. | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.20 | homo-hexamer | 3 x MG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6vww.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6vww.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6vww.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6vww.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6vww.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6w01.1.E | Uridylate-specific endoribonuclease
The 1.9 A Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with a Citrate | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.90 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6w01.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6w01.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6w01.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6w01.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6w01.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6vww.1.E | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2. | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.20 | homo-hexamer | 3 x MG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6vww.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6vww.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6vww.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6vww.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6vww.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6w01.1.F | Uridylate-specific endoribonuclease
The 1.9 A Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with a Citrate | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.90 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6w01.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6w01.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6w01.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6w01.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6w01.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6w01.1.B | Uridylate-specific endoribonuclease
The 1.9 A Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with a Citrate | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.90 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6w01.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6w01.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6w01.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6w01.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6w01.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6w01.1.C | Uridylate-specific endoribonuclease
The 1.9 A Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with a Citrate | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.90 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6w01.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6w01.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6w01.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6w01.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6w01.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6vww.1.D | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2. | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.20 | homo-hexamer | 3 x MG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6vww.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6vww.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6vww.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6vww.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6vww.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6vww.1.B | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2. | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.20 | homo-hexamer | 3 x MG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6vww.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6vww.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6vww.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6vww.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6vww.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6vww.1.C | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2. | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 2.20 | homo-hexamer | 3 x MG | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6vww.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6vww.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6vww.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6vww.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6vww.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7k1o.1.F | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-3',5'-Diphosphate | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.40 | homo-hexamer | 6 x VQV | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7k1o.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7k1o.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7k1o.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7k1o.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7k1o.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7k1o.1.E | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-3',5'-Diphosphate | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.40 | homo-hexamer | 6 x VQV | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7k1o.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7k1o.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7k1o.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7k1o.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7k1o.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7k1o.1.C | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-3',5'-Diphosphate | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.40 | homo-hexamer | 6 x VQV | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7k1o.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7k1o.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7k1o.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7k1o.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7k1o.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7k1o.1.B | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-3',5'-Diphosphate | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.40 | homo-hexamer | 6 x VQV | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7k1o.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7k1o.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7k1o.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7k1o.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7k1o.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7k1o.1.A | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-3',5'-Diphosphate | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.40 | homo-hexamer | 6 x VQV | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7k1o.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7k1o.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7k1o.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7k1o.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7k1o.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7k1o.1.D | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-3',5'-Diphosphate | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.40 | homo-hexamer | 6 x VQV | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7k1o.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7k1o.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7k1o.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7k1o.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7k1o.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6wlc.1.E | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-5'-Monophosphate | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.82 | homo-hexamer | 6 x U5P | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6wlc.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6wlc.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6wlc.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6wlc.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6wlc.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6x1b.1.D | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with the Product Nucleotide GpU. | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 1.97 | homo-hexamer | 6 x G-U | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6x1b.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6x1b.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6x1b.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6x1b.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6x1b.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6x4i.1.D | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with 3'-uridinemonophosphate | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.85 | homo-hexamer | 6 x U3P | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6x4i.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6x4i.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6x4i.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6x4i.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6x4i.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6wxc.1.B | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with potential repurposing drug Tipiracil | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.85 | homo-hexamer | 6 x CMU | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6wxc.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6wxc.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6wxc.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6wxc.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6wxc.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6x4i.1.A | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with 3'-uridinemonophosphate | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.85 | homo-hexamer | 6 x U3P | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6x4i.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6x4i.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6x4i.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6x4i.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6x4i.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6wxc.1.C | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with potential repurposing drug Tipiracil | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.85 | homo-hexamer | 6 x CMU | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6wxc.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6wxc.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6wxc.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6wxc.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6wxc.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7k1l.1.A | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-2',3'-Vanadate | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.25 | homo-hexamer | 6 x UVC | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7k1l.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7k1l.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7k1l.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7k1l.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7k1l.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6x1b.1.B | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with the Product Nucleotide GpU. | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 1.97 | homo-hexamer | 6 x G-U | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6x1b.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6x1b.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6x1b.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6x1b.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6x1b.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6x4i.1.B | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with 3'-uridinemonophosphate | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.85 | homo-hexamer | 6 x U3P | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6x4i.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6x4i.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6x4i.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6x4i.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6x4i.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7k1l.1.C | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-2',3'-Vanadate | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.25 | homo-hexamer | 6 x UVC | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7k1l.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7k1l.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7k1l.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7k1l.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7k1l.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6wxc.1.E | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with potential repurposing drug Tipiracil | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.85 | homo-hexamer | 6 x CMU | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6wxc.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6wxc.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6wxc.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6wxc.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6wxc.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6wlc.1.B | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-5'-Monophosphate | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.82 | homo-hexamer | 6 x U5P | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6wlc.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6wlc.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6wlc.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6wlc.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6wlc.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6wxc.1.A | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with potential repurposing drug Tipiracil | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.85 | homo-hexamer | 6 x CMU | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6wxc.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6wxc.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6wxc.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6wxc.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6wxc.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6wxc.1.F | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with potential repurposing drug Tipiracil | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.85 | homo-hexamer | 6 x CMU | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6wxc.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6wxc.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6wxc.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6wxc.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6wxc.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6wlc.1.F | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-5'-Monophosphate | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.82 | homo-hexamer | 6 x U5P | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6wlc.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6wlc.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6wlc.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6wlc.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6wlc.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6x4i.1.E | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with 3'-uridinemonophosphate | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.85 | homo-hexamer | 6 x U3P | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6x4i.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6x4i.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6x4i.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6x4i.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6x4i.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6x1b.1.F | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with the Product Nucleotide GpU. | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 1.97 | homo-hexamer | 6 x G-U | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6x1b.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6x1b.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6x1b.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6x1b.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6x1b.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6x4i.1.F | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with 3'-uridinemonophosphate | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.85 | homo-hexamer | 6 x U3P | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6x4i.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6x4i.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6x4i.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6x4i.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6x4i.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6wlc.1.D | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-5'-Monophosphate | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.82 | homo-hexamer | 6 x U5P | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6wlc.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6wlc.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6wlc.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6wlc.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6wlc.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7k1l.1.E | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-2',3'-Vanadate | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.25 | homo-hexamer | 6 x UVC | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7k1l.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7k1l.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7k1l.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7k1l.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7k1l.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6wlc.1.C | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-5'-Monophosphate | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.82 | homo-hexamer | 6 x U5P | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6wlc.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6wlc.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6wlc.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6wlc.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6wlc.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7k1l.1.F | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-2',3'-Vanadate | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.25 | homo-hexamer | 6 x UVC | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7k1l.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7k1l.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7k1l.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7k1l.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7k1l.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
✓
| 6wlc.1.A | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-5'-Monophosphate | 0.99 | 0.92 | 100.00 | 1.00 | 1-346 | X-ray | 1.82 | homo-hexamer | 6 x U5P | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6wlc.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6wlc.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6wlc.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6wlc.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6wlc.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7k1l.1.D | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-2',3'-Vanadate | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.25 | homo-hexamer | 6 x UVC | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7k1l.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7k1l.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7k1l.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7k1l.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7k1l.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6wxc.1.D | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with potential repurposing drug Tipiracil | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.85 | homo-hexamer | 6 x CMU | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6wxc.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6wxc.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6wxc.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6wxc.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6wxc.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6x4i.1.C | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with 3'-uridinemonophosphate | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.85 | homo-hexamer | 6 x U3P | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6x4i.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6x4i.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6x4i.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6x4i.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6x4i.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7k1l.1.B | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-2',3'-Vanadate | 0.98 | | 100.00 | 1.00 | 1-346 | X-ray | 2.25 | homo-hexamer | 6 x UVC | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7k1l.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7k1l.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7k1l.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7k1l.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7k1l.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6x1b.1.A | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with the Product Nucleotide GpU. | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.97 | homo-hexamer | 6 x G-U | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6x1b.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6x1b.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6x1b.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6x1b.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6x1b.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6x1b.1.E | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with the Product Nucleotide GpU. | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.97 | homo-hexamer | 6 x G-U | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6x1b.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6x1b.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6x1b.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6x1b.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6x1b.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 6x1b.1.C | Uridylate-specific endoribonuclease
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with the Product Nucleotide GpU. | 0.99 | | 100.00 | 1.00 | 1-346 | X-ray | 1.97 | homo-hexamer | 6 x G-U | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 6x1b.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 6x1b.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 6x1b.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 6x1b.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 6x1b.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7tqv.1.A | Uridylate-specific endoribonuclease
SARS-CoV-2 endoribonuclease Nsp15 bound to dsRNA | 0.97 | | 99.71 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7tqv.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7tqv.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7tqv.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEAIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7tqv.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7tqv.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7tqv.1.B | Uridylate-specific endoribonuclease
SARS-CoV-2 endoribonuclease Nsp15 bound to dsRNA | 0.97 | | 99.71 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7tqv.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7tqv.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7tqv.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEAIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7tqv.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7tqv.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7tqv.1.C | Uridylate-specific endoribonuclease
SARS-CoV-2 endoribonuclease Nsp15 bound to dsRNA | 0.97 | | 99.71 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7tqv.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7tqv.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7tqv.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEAIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7tqv.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7tqv.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7tqv.1.D | Uridylate-specific endoribonuclease
SARS-CoV-2 endoribonuclease Nsp15 bound to dsRNA | 0.97 | | 99.71 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7tqv.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7tqv.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7tqv.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEAIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7tqv.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7tqv.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7tqv.1.E | Uridylate-specific endoribonuclease
SARS-CoV-2 endoribonuclease Nsp15 bound to dsRNA | 0.97 | | 99.71 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7tqv.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7tqv.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7tqv.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEAIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7tqv.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7tqv.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7tqv.1.F | Uridylate-specific endoribonuclease
SARS-CoV-2 endoribonuclease Nsp15 bound to dsRNA | 0.97 | | 99.71 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7tqv.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7tqv.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7tqv.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEAIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7tqv.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7tqv.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7tj2.1.A | Uridylate-specific endoribonuclease nsp15
SARS-CoV-2 endoribonuclease Nsp15 bound to dsRNA | 0.97 | | 99.71 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7tj2.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7tj2.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7tj2.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEAIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7tj2.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7tj2.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7tj2.1.B | Uridylate-specific endoribonuclease nsp15
SARS-CoV-2 endoribonuclease Nsp15 bound to dsRNA | 0.97 | | 99.71 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7tj2.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7tj2.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7tj2.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEAIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7tj2.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7tj2.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7tj2.1.C | Uridylate-specific endoribonuclease nsp15
SARS-CoV-2 endoribonuclease Nsp15 bound to dsRNA | 0.97 | | 99.71 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7tj2.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7tj2.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7tj2.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEAIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7tj2.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7tj2.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7tj2.1.D | Uridylate-specific endoribonuclease nsp15
SARS-CoV-2 endoribonuclease Nsp15 bound to dsRNA | 0.81 | | 99.71 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7tj2.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7tj2.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7tj2.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEAIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7tj2.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7tj2.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7tj2.1.E | Uridylate-specific endoribonuclease nsp15
SARS-CoV-2 endoribonuclease Nsp15 bound to dsRNA | 0.97 | | 99.71 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7tj2.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7tj2.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7tj2.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEAIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7tj2.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7tj2.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7tj2.1.F | Uridylate-specific endoribonuclease nsp15
SARS-CoV-2 endoribonuclease Nsp15 bound to dsRNA | 0.96 | | 99.71 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7tj2.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7tj2.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7tj2.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEAIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7tj2.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7tj2.1 TIDYTEISFMLWCKDGHVETFYPKLQ
|
| 7n06.1.A | Uridylate-specific endoribonuclease
SARS-CoV-2 Nsp15 endoribonuclease post-cleavage state | 0.99 | | 100.00 | 1.00 | 1-345 | EM | 0.00 | homo-hexamer | 6 x A-U-A | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n06.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n06.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n06.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n06.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n06.1 TIDYTEISFMLWCKDGHVETFYPKL-
|
| 7n06.1.B | Uridylate-specific endoribonuclease
SARS-CoV-2 Nsp15 endoribonuclease post-cleavage state | 0.99 | | 100.00 | 1.00 | 1-345 | EM | 0.00 | homo-hexamer | 6 x A-U-A | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n06.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n06.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n06.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n06.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n06.1 TIDYTEISFMLWCKDGHVETFYPKL-
|
| 7n06.1.C | Uridylate-specific endoribonuclease
SARS-CoV-2 Nsp15 endoribonuclease post-cleavage state | 0.99 | | 100.00 | 1.00 | 1-345 | EM | 0.00 | homo-hexamer | 6 x A-U-A | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n06.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n06.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n06.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n06.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n06.1 TIDYTEISFMLWCKDGHVETFYPKL-
|
| 7n06.1.D | Uridylate-specific endoribonuclease
SARS-CoV-2 Nsp15 endoribonuclease post-cleavage state | 0.98 | | 100.00 | 1.00 | 1-345 | EM | 0.00 | homo-hexamer | 6 x A-U-A | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n06.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n06.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n06.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n06.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n06.1 TIDYTEISFMLWCKDGHVETFYPKL-
|
| 7n06.1.E | Uridylate-specific endoribonuclease
SARS-CoV-2 Nsp15 endoribonuclease post-cleavage state | 0.98 | | 100.00 | 1.00 | 1-345 | EM | 0.00 | homo-hexamer | 6 x A-U-A | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n06.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n06.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n06.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n06.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n06.1 TIDYTEISFMLWCKDGHVETFYPKL-
|
| 7n06.1.F | Uridylate-specific endoribonuclease
SARS-CoV-2 Nsp15 endoribonuclease post-cleavage state | 0.98 | | 100.00 | 1.00 | 1-345 | EM | 0.00 | homo-hexamer | 6 x A-U-A | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n06.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n06.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n06.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n06.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n06.1 TIDYTEISFMLWCKDGHVETFYPKL-
|
| 7n33.1.A | Uridylate-specific endoribonuclease
SARS-CoV-2 Nsp15 endoribonuclease pre-cleavage state | 0.98 | | 100.00 | 0.99 | 1-344 | EM | 0.00 | homo-hexamer | 6 x UFT-A | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n33.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n33.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n33.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n33.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n33.1 TIDYTEISFMLWCKDGHVETFYPK--
|
| 7n33.1.B | Uridylate-specific endoribonuclease
SARS-CoV-2 Nsp15 endoribonuclease pre-cleavage state | 0.98 | | 100.00 | 0.99 | 1-344 | EM | 0.00 | homo-hexamer | 6 x UFT-A | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n33.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n33.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n33.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n33.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n33.1 TIDYTEISFMLWCKDGHVETFYPK--
|
| 7n33.1.C | Uridylate-specific endoribonuclease
SARS-CoV-2 Nsp15 endoribonuclease pre-cleavage state | 0.98 | | 100.00 | 0.99 | 1-344 | EM | 0.00 | homo-hexamer | 6 x UFT-A | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n33.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n33.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n33.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n33.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n33.1 TIDYTEISFMLWCKDGHVETFYPK--
|
| 7n33.1.D | Uridylate-specific endoribonuclease
SARS-CoV-2 Nsp15 endoribonuclease pre-cleavage state | 0.98 | | 100.00 | 0.99 | 1-344 | EM | 0.00 | homo-hexamer | 6 x UFT-A | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n33.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n33.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n33.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n33.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n33.1 TIDYTEISFMLWCKDGHVETFYPK--
|
| 7n33.1.E | Uridylate-specific endoribonuclease
SARS-CoV-2 Nsp15 endoribonuclease pre-cleavage state | 0.98 | | 100.00 | 0.99 | 1-344 | EM | 0.00 | homo-hexamer | 6 x UFT-A | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n33.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n33.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n33.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n33.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n33.1 TIDYTEISFMLWCKDGHVETFYPK--
|
| 7n33.1.F | Uridylate-specific endoribonuclease
SARS-CoV-2 Nsp15 endoribonuclease pre-cleavage state | 0.98 | | 100.00 | 0.99 | 1-344 | EM | 0.00 | homo-hexamer | 6 x UFT-A | HHblits | 0.61 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 7n33.1 SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 7n33.1 ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 7n33.1 SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 7n33.1 SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 7n33.1 TIDYTEISFMLWCKDGHVETFYPK--
|
| 2ozk.1.A | Uridylate-specific endoribonuclease
Structure of an N-Terminal Truncated Form of Nendou (NSP15) From SARS-CORONAVIRUS | 0.83 | 0.59 | 88.73 | 1.00 | 1-346 | X-ray | 2.90 | homo-tetramer | | HHblits | 0.58 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 2ozk.1 SLENVAYNVVNKGHFDGHAGEAPVSIINNAVYTKVDGIDVEIFENKTTLPVNVAFELWAKRNIKPVPEIKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 2ozk.1 ANTVIWDYKREAPAHVSTIGVCTMTDIAKKPTESACSSLTVLFDGRVEGQVDLFRNARNGVLITEGSVKGLTPSKGPAQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 2ozk.1 SVNGVTLIGESVKTQFNYFKKVDGIIQQLPETYFTQSRDLEDFKPRSQMETDFLELAMDEFIQRYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 2ozk.1 SHGQLGGLHLMIGLAKRSQDSPLKLEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVISKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 2ozk.1 TIDYAEISFMLWCKDGHVETFYPKLQ
|
| 2ozk.1.C | Uridylate-specific endoribonuclease
Structure of an N-Terminal Truncated Form of Nendou (NSP15) From SARS-CORONAVIRUS | 0.79 | 0.57 | 88.73 | 1.00 | 1-346 | X-ray | 2.90 | homo-tetramer | | HHblits | 0.58 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 2ozk.1 SLENVAYNVVNKGHFDGHAGEAPVSIINNAVYTKVDGIDVEIFENKTTLPVNVAFELWAKRNIKPVPEIKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 2ozk.1 ANTVIWDYKREAPAHVSTIGVCTMTDIAKKPTESACSSLTVLFDGRVEGQVDLFRNARNGVLITEGSVKGLTPSKGPAQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 2ozk.1 SVNGVTLIGESVKTQFNYFKKVDGIIQQLPETYFTQSRDLEDFKPRSQMETDFLELAMDEFIQRYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 2ozk.1 SHGQLGGLHLMIGLAKRSQDSPLKLEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVISKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 2ozk.1 TIDYAEISFMLWCKDGHVETFYPKLQ
|
| 2ozk.1.D | Uridylate-specific endoribonuclease
Structure of an N-Terminal Truncated Form of Nendou (NSP15) From SARS-CORONAVIRUS | 0.79 | 0.58 | 88.73 | 1.00 | 1-346 | X-ray | 2.90 | homo-tetramer | | HHblits | 0.58 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 2ozk.1 SLENVAYNVVNKGHFDGHAGEAPVSIINNAVYTKVDGIDVEIFENKTTLPVNVAFELWAKRNIKPVPEIKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 2ozk.1 ANTVIWDYKREAPAHVSTIGVCTMTDIAKKPTESACSSLTVLFDGRVEGQVDLFRNARNGVLITEGSVKGLTPSKGPAQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 2ozk.1 SVNGVTLIGESVKTQFNYFKKVDGIIQQLPETYFTQSRDLEDFKPRSQMETDFLELAMDEFIQRYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 2ozk.1 SHGQLGGLHLMIGLAKRSQDSPLKLEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVISKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 2ozk.1 TIDYAEISFMLWCKDGHVETFYPKLQ
|
✓
| 2rhb.1.A | Uridylate-specific endoribonuclease
Crystal structure of Nsp15-H234A mutant- Hexamer in asymmetric unit | 0.96 | 0.88 | 88.44 | 1.00 | 1-346 | X-ray | 2.80 | homo-hexamer | | HHblits | 0.58 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 2rhb.1 SLENVAYNVVNKGHFDGHAGEAPVSIINNAVYTKVDGIDVEIFENKTTLPVNVAFELWAKRNIKPVPEIKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 2rhb.1 ANTVIWDYKREAPAHVSTIGVCTMTDIAKKPTESACSSLTVLFDGRVEGQVDLFRNARNGVLITEGSVKGLTPSKGPAQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 2rhb.1 SVNGVTLIGESVKTQFNYFKKVDGIIQQLPETYFTQSRDLEDFKPRSQMETDFLELAMDEFIQRYKLEGYAFEAIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 2rhb.1 SHGQLGGLHLMIGLAKRSQDSPLKLEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVISKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 2rhb.1 TIDYAEISFMLWCKDGHVETFYPKLQ
|
✓
| 2h85.1.A | Putative orf1ab polyprotein
Crystal Structure of Nsp 15 from SARS | 0.96 | 0.87 | 88.12 | 1.00 | 1-345 | X-ray | 2.60 | homo-hexamer | | HHblits | 0.58 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 2h85.1 SLENVAYNVVNKGHFDGHAGEAPVSIINNAVYTKVDGIDVEIFENKTTLPVNVAFELWAKRNIKPVPEIKILNNLGVDIA
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 2h85.1 ANTVIWDYKREAPAHVSTIGVCTMTDIAKKPTESACSSLTVLFDGRVEGQVDLFRNARNGVLITEGSVKGLTPSKGPAQA
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 2h85.1 SVNGVTLIGESVKTQFNYFKKVDGIIQQLPETYFTQSRDLEDFKPRSQMETDFLELAMDEFIQRYKLEGYAFEHIVYGDF
target SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV 2h85.1 SHGQLGGLHLMIGLAKRSQDSPLKLEDFIPMDSTVKNYFITDAQTGSSKCGCSVIDLLLGDFVEIIKSQDLSVISKVVKV
target TIDYTEISFMLWCKDGHVETFYPKLQ 2h85.1 TIDYAEISFMLWCKDGHVETFYPKL-
|
| 5yvd.1.A | Nsp15
Structural and biochemical characterization of endoribonuclease Nsp15 encoded by Middle East Respiratory Syndrome Coronavirus | 0.80 | | 52.21 | 0.98 | 2-346 | X-ray | 2.70 | homo-hexamer | | BLAST | 0.44 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5yvd.1 -LENIAFNVVKQGHFIGVEGELPVAVVNDKIFTKSGVNDICMFENKTTLPTNIAFELYAKRAVRSHPDFKLLHNLQADIC
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5yvd.1 YKFVLWDYERSNIYGTATIGVCKYTDIDVNSALNIC------FDIRDNCSLEKFMSTPNAIFISDRKIKKYPCMVGPDYA
target SLNGVTLIGEAVKTQ---FNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVY 5yvd.1 YFNGAIIRDSDVVKQPVKFYLYKKVNNEFIDPTECIYTQSRSCSDFLPLSDMEKDFLSFDSDVFIKKYGLENYAFEHVVY
target GDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKV 5yvd.1 GDFSHTTLGGLHLLIGLYKRQQEGHIIMEEMLKGSSTIHNYFITETNTAAFKAVCSVIDLKLDDFVMILKSQDLGVVSKV
target VKVTIDYTEISFMLWCKDGHVETFYPKLQ 5yvd.1 VKVPIDLTMIEFMLWCKDGQVQTFYPRLQ
|
| 5yvd.1.A | Nsp15
Structural and biochemical characterization of endoribonuclease Nsp15 encoded by Middle East Respiratory Syndrome Coronavirus | 0.81 | | 51.18 | 0.98 | 1-346 | X-ray | 2.70 | homo-hexamer | | HHblits | 0.44 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5yvd.1 GLENIAFNVVKQGHFIGVEGELPVAVVNDKIFTKSGVNDICMFENKTTLPTNIAFELYAKRAVRSHPDFKLLHNLQADIC
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5yvd.1 YKFVLWDYERSNIYGTATIGVCKYTDIDV------NSALNICFDIRDNCSLEKFMSTPNAIFISDRKIKKYPCMVGPDYA
target SLNGVTLIGE---AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVY 5yvd.1 YFNGAIIRDSDVVKQPVKFYLYKKVNNEFIDPTECIYTQSRSCSDFLPLSDMEKDFLSFDSDVFIKKYGLENYAFEHVVY
target GDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKV 5yvd.1 GDFSHTTLGGLHLLIGLYKRQQEGHIIMEEMLKGSSTIHNYFITETNTAAFKAVCSVIDLKLDDFVMILKSQDLGVVSKV
target VKVTIDYTEISFMLWCKDGHVETFYPKLQ 5yvd.1 VKVPIDLTMIEFMLWCKDGQVQTFYPRLQ
|
| 2gth.1.A | Replicase polyprotein 1ab
crystal structure of the wildtype MHV coronavirus non-structural protein nsp15 | 0.76 | | 49.55 | 0.97 | 1-341 | X-ray | 2.70 | homo-hexamer | | BLAST | 0.44 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 2gth.1 SLENVVYNLVNAGHFDGRAGELPCAVIGEKVIAKIQNEDVVVFKNNTPFPTNVAVELFAKRSIRPHPELKLFRNLNIDVC
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 2gth.1 WSHVLWDYAKDSVFCSSTYKVCKYTDL------QCIESLNVLFDGRDNGALEAFKKCRNGVYINTTKIKSLSMIKGPQRA
target SLNGVTL--IGEA-VKTQFNYYKKVDGVV-----------QQLPE--------------------TYFTQSRNLQEFKPR 2gth.1 DLNGVVVEKVGDSDVEFWFAVRKDGDDVIFSRTGSLEPSHYRSPQGNPGGNRVGDLSGNEALARGTIFTQSRLLSSFTPR
target SQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 2gth.1 SEMEKDFMDLDDDVFIAKYSLQDYAFEHVVYGSFNQKIIGGLHLLIGLARRQQKSNLVIQEFVTYDSSIHSYFITDENSG
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 2gth.1 SSKSVCTVIDLLLDDFVDIVKSLNLKCVSKVVNVNVDFKDFQFMLWCNEEKVMTF-----
|
| 2gti.1.A | Replicase polyprotein 1ab
mutation of MHV coronavirus non-structural protein nsp15 (F307L) | 0.77 | | 49.25 | 0.97 | 1-341 | X-ray | 2.15 | homo-hexamer | | BLAST | 0.44 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 2gti.1 SLENVVYNLVNAGHFDGRAGELPCAVIGEKVIAKIQNEDVVVFKNNTPFPTNVAVELFAKRSIRPHPELKLFRNLNIDVC
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 2gti.1 WSHVLWDYAKDSVFCSSTYKVCKYTDL------QCIESLNVLFDGRDNGALEAFKKCRNGVYINTTKIKSLSMIKGPQRA
target SLNGVTL--IGEA-VKTQFNYYKKVDGVV-----------QQLPE--------------------TYFTQSRNLQEFKPR 2gti.1 DLNGVVVEKVGDSDVEFWFAVRKDGDDVIFSRTGSLEPSHYRSPQGNPGGNRVGDLSGNEALARGTIFTQSRLLSSFTPR
target SQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 2gti.1 SEMEKDFMDLDDDVFIAKYSLQDYAFEHVVYGSFNQKIIGGLHLLIGLARRQQKSNLVIQEFVTYDSSIHSYLITDENSG
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 2gti.1 SSKSVCTVIDLLLDDFVDIVKSLNLKCVSKVVNVNVDFKDFQFMLWCNEEKVMTF-----
|
| 2gth.1.A | Replicase polyprotein 1ab
crystal structure of the wildtype MHV coronavirus non-structural protein nsp15 | 0.78 | | 48.36 | 0.97 | 1-341 | X-ray | 2.70 | homo-hexamer | | HHblits | 0.43 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 2gth.1 SLENVVYNLVNAGHFDGRAGELPCAVIGEKVIAKIQNEDVVVFKNNTPFPTNVAVELFAKRSIRPHPELKLFRNLNIDVC
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 2gth.1 WSHVLWDYAKDSVFCSSTYKVCKYTDLQC------IESLNVLFDGRDNGALEAFKKCRNGVYINTTKIKSLSMIKGPQRA
target SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLP---------------------------------ETYFTQSRNLQEFKPR 2gth.1 DLNGVVVEKVGDSDVEFWFAVRKDGDDVIFSRTGSLEPSHYRSPQGNPGGNRVGDLSGNEALARGTIFTQSRLLSSFTPR
target SQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 2gth.1 SEMEKDFMDLDDDVFIAKYSLQDYAFEHVVYGSFNQKIIGGLHLLIGLARRQQKSNLVIQEFVTYDSSIHSYFITDENSG
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 2gth.1 SSKSVCTVIDLLLDDFVDIVKSLNLKCVSKVVNVNVDFKDFQFMLWCNEEKVMTF-----
|
| 2gti.1.A | Replicase polyprotein 1ab
mutation of MHV coronavirus non-structural protein nsp15 (F307L) | 0.78 | | 48.06 | 0.97 | 1-341 | X-ray | 2.15 | homo-hexamer | | HHblits | 0.43 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 2gti.1 SLENVVYNLVNAGHFDGRAGELPCAVIGEKVIAKIQNEDVVVFKNNTPFPTNVAVELFAKRSIRPHPELKLFRNLNIDVC
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 2gti.1 WSHVLWDYAKDSVFCSSTYKVCKYTDLQC------IESLNVLFDGRDNGALEAFKKCRNGVYINTTKIKSLSMIKGPQRA
target SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLP---------------------------------ETYFTQSRNLQEFKPR 2gti.1 DLNGVVVEKVGDSDVEFWFAVRKDGDDVIFSRTGSLEPSHYRSPQGNPGGNRVGDLSGNEALARGTIFTQSRLLSSFTPR
target SQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 2gti.1 SEMEKDFMDLDDDVFIAKYSLQDYAFEHVVYGSFNQKIIGGLHLLIGLARRQQKSNLVIQEFVTYDSSIHSYLITDENSG
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 2gti.1 SSKSVCTVIDLLLDDFVDIVKSLNLKCVSKVVNVNVDFKDFQFMLWCNEEKVMTF-----
|
| 4rs4.1.A | Uridylate-specific endoribonuclease
Crystal structure and mutational analysis of the endoribonuclease from human coronavirus 229E | 0.74 | | 45.67 | 0.97 | 2-346 | X-ray | 2.96 | homo-hexamer | | BLAST | 0.41 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 4rs4.1 -LENIAFNVVNKGSFVSADGELPVAISGDKVFVRDGNTDNLVFVNKTSLPTNIAFELFAKRKVGLTPPLSILKNLGVVAT
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 4rs4.1 YKFVLWDYEAERPLTSFTKSVCGYTDFA----EDVCTC----YDNSIQGSYERFTLSTNAVLFSATAVKAGGKSL--PAI
target SLNGVTLIGEAVKT---------QFNY--YKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEG 4rs4.1 KLNFGMLNGNAIATVKSEDGNIKNINWFVYVRKDGKPVDHYDGFYTQGRNLQDFLPRSTMEEDFLNMDMGVFIQKYGLED
target YAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPM-DSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKS 4rs4.1 FNFEHVVYGDVSKTTLGGLHLSISQVRLSKMGILKAEEFVAASDITLKCCTVTYLNDPSSKTVCTYMDLLLDDFVSVLKS
target QDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 4rs4.1 LDLTVVSKVHEVIIDNKPWRWMLWCKDNAVATFYPQLQ
|
| 4rs4.1.B | Uridylate-specific endoribonuclease
Crystal structure and mutational analysis of the endoribonuclease from human coronavirus 229E | 0.74 | | 45.67 | 0.97 | 2-346 | X-ray | 2.96 | homo-hexamer | | BLAST | 0.41 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 4rs4.1 -LENIAFNVVNKGSFVSADGELPVAISGDKVFVRDGNTDNLVFVNKTSLPTNIAFELFAKRKVGLTPPLSILKNLGVVAT
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 4rs4.1 YKFVLWDYEAERPLTSFTKSVCGYTDFA----EDVCTC----YDNSIQGSYERFTLSTNAVLFSATAVKAGGKSL--PAI
target SLNGVTLIGEAVKT---------QFNY--YKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEG 4rs4.1 KLNFGMLNGNAIATVKSEDGNIKNINWFVYVRKDGKPVDHYDGFYTQGRNLQDFLPRSTMEEDFLNMDMGVFIQKYGLED
target YAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPM-DSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKS 4rs4.1 FNFEHVVYGDVSKTTLGGLHLSISQVRLSKMGILKAEEFVAASDITLKCCTVTYLNDPSSKTVCTYMDLLLDDFVSVLKS
target QDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 4rs4.1 LDLTVVSKVHEVIIDNKPWRWMLWCKDNAVATFYPQLQ
|
| 4s1t.1.A | Uridylate-specific endoribonuclease
Crystal structure of the mutant I26A/N52A of the endoribonuclease from human coronavirus 229E | 0.74 | | 45.37 | 0.97 | 2-346 | X-ray | 2.50 | homo-hexamer | | BLAST | 0.41 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 4s1t.1 -LENIAFNVVNKGSFVGADGELPVAASGDKVFVRDGNTDNLVFVNKTSLPTAIAFELFAKRKVGLTPPLSILKNLGVVAT
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 4s1t.1 YKFVLWDYEAERPLTSFTKSVCGYTDFA----EDVCTC----YDNSIQGSYERFTLSTNAVLFSATAVKTGGKSL--PAI
target SLNGVTLIGEAVKT---------QFNY--YKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEG 4s1t.1 KLNFGMLNGNAIATVKSEDGNIKNINWFVYVRKDGKPVDHYDGFYTQGRNLQDFLPRSTMEEDFLNMDIGVFIQKYGLED
target YAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPM-DSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKS 4s1t.1 FNFEHVVYGDVSKTTLGGLHLLISQVRLSKMGILKAEEFVAASDITLKCCTVTYLNDPSSKTVCTYMDLLLDDFVSVLKS
target QDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 4s1t.1 LDLTVVSKVHEVIIDNKPWRWMLWCKDNAVATFYPQLQ
|
| 4rs4.1.A | Uridylate-specific endoribonuclease
Crystal structure and mutational analysis of the endoribonuclease from human coronavirus 229E | 0.75 | | 43.62 | 0.97 | 1-346 | X-ray | 2.96 | homo-hexamer | | HHblits | 0.40 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 4rs4.1 GLENIAFNVVNKGSFVSADGELPVAISGDKVFVRDGNTDNLVFVNKTSLPTNIAFELFAKRKVGLTPPLSILKNLGVVAT
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVK----GLQPSVG 4rs4.1 YKFVLWDYEAERPLTSFTKSVCGYTDFA--------EDVCTCYDNSIQGSYERFTLSTNAVLFSATAVKAGGKSLPAIK-
target PKQASLNGVTLIGE------AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGY 4rs4.1 LNFGMLNGNAIATVKSEDGNIKNINWFVYVRKDGKPVDHYDGFYTQGRNLQDFLPRSTMEEDFLNMDMGVFIQKYGLEDF
target AFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPM-DSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQ 4rs4.1 NFEHVVYGDVSKTTLGGLHLSISQVRLSKMGILKAEEFVAASDITLKCCTVTYLNDPSSKTVCTYMDLLLDDFVSVLKSL
target DLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 4rs4.1 DLTVVSKVHEVIIDNKPWRWMLWCKDNAVATFYPQLQ
|
| 4rs4.1.B | Uridylate-specific endoribonuclease
Crystal structure and mutational analysis of the endoribonuclease from human coronavirus 229E | 0.75 | | 43.62 | 0.97 | 1-346 | X-ray | 2.96 | homo-hexamer | | HHblits | 0.40 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 4rs4.1 GLENIAFNVVNKGSFVSADGELPVAISGDKVFVRDGNTDNLVFVNKTSLPTNIAFELFAKRKVGLTPPLSILKNLGVVAT
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVK----GLQPSVG 4rs4.1 YKFVLWDYEAERPLTSFTKSVCGYTDFA--------EDVCTCYDNSIQGSYERFTLSTNAVLFSATAVKAGGKSLPAIK-
target PKQASLNGVTLIGE------AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGY 4rs4.1 LNFGMLNGNAIATVKSEDGNIKNINWFVYVRKDGKPVDHYDGFYTQGRNLQDFLPRSTMEEDFLNMDMGVFIQKYGLEDF
target AFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPM-DSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQ 4rs4.1 NFEHVVYGDVSKTTLGGLHLSISQVRLSKMGILKAEEFVAASDITLKCCTVTYLNDPSSKTVCTYMDLLLDDFVSVLKSL
target DLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 4rs4.1 DLTVVSKVHEVIIDNKPWRWMLWCKDNAVATFYPQLQ
|
| 4s1t.1.A | Uridylate-specific endoribonuclease
Crystal structure of the mutant I26A/N52A of the endoribonuclease from human coronavirus 229E | 0.75 | | 43.32 | 0.97 | 1-346 | X-ray | 2.50 | homo-hexamer | | HHblits | 0.40 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 4s1t.1 GLENIAFNVVNKGSFVGADGELPVAASGDKVFVRDGNTDNLVFVNKTSLPTAIAFELFAKRKVGLTPPLSILKNLGVVAT
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVK----GLQPSVG 4s1t.1 YKFVLWDYEAERPLTSFTKSVCGYTDFA--------EDVCTCYDNSIQGSYERFTLSTNAVLFSATAVKTGGKSLPAIK-
target PKQASLNGVTLIGE------AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGY 4s1t.1 LNFGMLNGNAIATVKSEDGNIKNINWFVYVRKDGKPVDHYDGFYTQGRNLQDFLPRSTMEEDFLNMDIGVFIQKYGLEDF
target AFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPM-DSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQ 4s1t.1 NFEHVVYGDVSKTTLGGLHLLISQVRLSKMGILKAEEFVAASDITLKCCTVTYLNDPSSKTVCTYMDLLLDDFVSVLKSL
target DLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 4s1t.1 DLTVVSKVHEVIIDNKPWRWMLWCKDNAVATFYPQLQ
|
| 5wwp.1.A | ORF1ab
Crystal structure of Middle East respiratory syndrome coronavirus helicase (MERS-CoV nsp13) | 0.24 | | 11.60 | 0.72 | 24-346 | X-ray | 3.00 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5wwp.1 -----------------------CVVCHSQTSLRCGTCIRRPF-----LCCKCCYDHVIATPHKMVLSVSPYVCNAPGCG
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5wwp.1 VSDVTKLYLGGMSYFCVD-HRPVCSF--PLCA----N--------GLVFGLYKNMCTGSPSIVEFNRLATCDWTESGDYT
target --------GVLITEGSVKGL-QPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5wwp.1 LANTTTEPLKLFAAETLRATEEASK-QSYAIATIKEIVGERQLLLVWEAG------------------KSKPPLNRNYVF
target EIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSK 5wwp.1 TGYHITK-----NSKVQLGEYIFERIDYSDAV-SYKSS-----TTYKLTV-----GDIFVLTSH-----SVATLTAPTIV
target CVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5wwp.1 NQERYVKITG-LYPTI-------TVPEEFASHVANF-----QKSGYSKYVTVQGPPG
|
| 5wwp.2.A | ORF1ab
Crystal structure of Middle East respiratory syndrome coronavirus helicase (MERS-CoV nsp13) | 0.19 | | 11.60 | 0.72 | 24-346 | X-ray | 3.00 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5wwp.2 -----------------------CVVCHSQTSLRCGTCIRRPF-----LCCKCCYDHVIATPHKMVLSVSPYVCNAPGCG
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5wwp.2 VSDVTKLYLGGMSYFCVD-HRPVCSF--PLCA----N--------GLVFGLYKNMCTGSPSIVEFNRLATCDWTESGDYT
target --------GVLITEGSVKGL-QPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5wwp.2 LANTTTEPLKLFAAETLRATEEASK-QSYAIATIKEIVGERQLLLVWEAG------------------KSKPPLNRNYVF
target EIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSK 5wwp.2 TGYHITK-----NSKVQLGEYIFERIDYSDAV-SYKSS-----TTYKLTV-----GDIFVLTSH-----SVATLTAPTIV
target CVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5wwp.2 NQERYVKITG-LYPTI-------TVPEEFASHVANF-----QKSGYSKYVTVQGPPG
|
| 5rob.2.A | Helicase
PanDDA analysis group deposition of ground-state model of SARS-CoV-2 helicase | 0.16 | | 11.27 | 0.62 | 24-299 | X-ray | 1.87 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rob.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rob.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rob.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rob.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rob.2 TLVPQEHYVRITG-----------------------------------------------
|
| 7nng.2.A | SARS-CoV-2 helicase NSP13
Crystal structure of the SARS-CoV-2 helicase in complex with Z2327226104 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.38 | monomer | 1 x UJK, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7nng.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7nng.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7nng.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7nng.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7nng.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlp.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z166605480 | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 2.56 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlp.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlp.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlp.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlp.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlp.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlr.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z822382694 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.32 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlr.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlr.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlr.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlr.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlr.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlj.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1407673036 | 0.16 | | 11.27 | 0.62 | 24-299 | X-ray | 1.88 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlj.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlj.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlj.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlj.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlj.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlw.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z45705015 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 1.97 | monomer | 1 x S9S, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlw.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlw.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlw.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlw.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlw.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rl8.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z53825177 | 0.16 | | 11.27 | 0.62 | 24-299 | X-ray | 2.21 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rl8.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rl8.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rl8.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rl8.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rl8.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rmc.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z24758179 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.15 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rmc.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rmc.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rmc.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rmc.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rmc.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlc.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z56923284 | 0.16 | | 11.27 | 0.62 | 24-299 | X-ray | 1.92 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlc.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlc.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlc.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlc.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlc.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rmi.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z53860899 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.12 | monomer | 1 x STV, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rmi.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rmi.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rmi.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rmi.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rmi.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rm0.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1492796719 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 1.91 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rm0.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rm0.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rm0.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rm0.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rm0.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rl6.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z198195770 | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 1.92 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rl6.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rl6.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rl6.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rl6.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rl6.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rm2.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1741964527 | 0.16 | | 11.27 | 0.62 | 24-299 | X-ray | 1.82 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rm2.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rm2.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rm2.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rm2.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rm2.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlv.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z2467208649 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.21 | monomer | 2 x VWJ, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlv.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlv.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlv.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlv.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlv.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rmk.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1273312153 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.08 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rmk.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rmk.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rmk.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rmk.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rmk.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlm.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1650168321 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 1.86 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlm.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlm.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlm.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlm.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlm.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rmd.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z57614330 | 0.16 | | 11.27 | 0.62 | 24-299 | X-ray | 1.92 | monomer | 1 x VWY, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rmd.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rmd.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rmd.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rmd.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rmd.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rmj.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z68299550 | 0.16 | | 11.27 | 0.62 | 24-299 | X-ray | 2.10 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rmj.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rmj.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rmj.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rmj.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rmj.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlh.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z2856434778 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.38 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlh.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlh.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlh.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlh.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlh.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rm4.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1639162606 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.96 | monomer | 1 x PK4, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rm4.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rm4.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rm4.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rm4.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rm4.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlz.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z2293643386 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 1.97 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlz.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlz.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlz.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlz.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlz.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rle.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1429867185 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.27 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rle.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rle.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rle.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rle.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rle.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rl9.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1703168683 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 1.79 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rl9.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rl9.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rl9.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rl9.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rl9.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlt.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z53116498 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.43 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlt.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlt.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlt.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlt.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlt.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rll.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z425387594 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.08 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rll.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rll.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rll.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rll.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rll.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rm3.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1745658474 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.09 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rm3.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rm3.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rm3.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rm3.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rm3.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlo.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1454310449 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.10 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlo.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlo.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlo.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlo.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlo.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rli.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z45617795 | 0.16 | | 11.27 | 0.62 | 24-299 | X-ray | 2.26 | monomer | 1 x JFM, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rli.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rli.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rli.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rli.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rli.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rml.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z85956652 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.43 | monomer | 1 x VXD, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rml.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rml.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rml.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rml.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rml.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlb.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z216450634 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 1.98 | monomer | 1 x VVJ, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlb.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlb.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlb.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlb.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlb.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rld.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z19735981 | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 2.23 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rld.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rld.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rld.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rld.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rld.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rln.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z364328788 | 0.16 | | 11.27 | 0.62 | 24-299 | X-ray | 2.15 | monomer | 1 x NZG, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rln.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rln.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rln.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rln.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rln.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rm8.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1614545742 | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 2.14 | monomer | 1 x GQJ, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rm8.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rm8.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rm8.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rm8.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rm8.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rmm.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with POB0066 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.20 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rmm.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rmm.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rmm.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rmm.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rmm.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rm7.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z69118333 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 1.84 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rm7.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rm7.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rm7.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rm7.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rm7.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rm9.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z2856434942 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.08 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rm9.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rm9.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rm9.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rm9.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rm9.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlq.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z285782452 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.23 | monomer | 1 x UVA, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlq.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlq.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlq.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlq.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlq.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rmb.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z2856434920 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.21 | monomer | 1 x VWV, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rmb.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rmb.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rmb.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rmb.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rmb.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rmh.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1101755952 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.02 | monomer | 1 x VX4, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rmh.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rmh.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rmh.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rmh.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rmh.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rl7.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z364321922 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 1.89 | monomer | 1 x VVD, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rl7.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rl7.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rl7.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rl7.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rl7.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rm1.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z426041412 | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 1.90 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rm1.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rm1.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rm1.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rm1.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rm1.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlu.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z744754722 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.35 | monomer | 1 x JG4, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlu.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlu.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlu.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlu.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlu.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rmg.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z285675722 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.12 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rmg.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rmg.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rmg.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rmg.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rmg.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rme.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z26333434 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.23 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rme.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rme.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rme.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rme.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rme.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rm6.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z396380540 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.13 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rm6.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rm6.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rm6.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rm6.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rm6.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlk.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1509882419 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 1.96 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlk.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlk.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlk.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlk.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlk.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rls.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z59181945 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.28 | monomer | 1 x VWG, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rls.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rls.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rls.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rls.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rls.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rma.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z321318226 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 1.89 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rma.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rma.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rma.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rma.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rma.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rly.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z2027049478 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.43 | monomer | 1 x K34, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rly.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rly.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rly.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rly.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rly.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rmf.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z54226006 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.23 | monomer | 1 x NX7, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rmf.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rmf.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rmf.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rmf.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rmf.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlg.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z19739650 | 0.16 | | 11.27 | 0.62 | 24-299 | X-ray | 1.96 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlg.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlg.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlg.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlg.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlg.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlf.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z235341991 | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 2.24 | monomer | 1 x NY7, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlf.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlf.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlf.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlf.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlf.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rm5.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z373768900 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.06 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rm5.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rm5.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rm5.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rm5.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rm5.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rob.1.A | Helicase
PanDDA analysis group deposition of ground-state model of SARS-CoV-2 helicase | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 1.87 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rob.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rob.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rob.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rob.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rob.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7nng.1.A | SARS-CoV-2 helicase NSP13
Crystal structure of the SARS-CoV-2 helicase in complex with Z2327226104 | 0.16 | | 11.27 | 0.62 | 24-299 | X-ray | 2.38 | monomer | 1 x UJK, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7nng.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7nng.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7nng.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7nng.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7nng.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlw.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z45705015 | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 1.97 | monomer | 1 x S9S, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlw.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlw.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlw.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlw.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlw.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rm7.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z69118333 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 1.84 | monomer | 1 x N0E, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rm7.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rm7.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rm7.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rm7.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rm7.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rld.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z19735981 | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 2.23 | monomer | 1 x VVY, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rld.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rld.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rld.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rld.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rld.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlk.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1509882419 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 1.96 | monomer | 1 x NYV, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlk.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlk.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlk.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlk.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlk.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlg.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z19739650 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 1.96 | monomer | 1 x VW1, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlg.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlg.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlg.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlg.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlg.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rm8.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1614545742 | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 2.14 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rm8.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rm8.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rm8.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rm8.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rm8.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlp.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z166605480 | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 2.56 | monomer | 1 x VWA, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlp.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlp.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlp.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlp.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlp.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rl6.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z198195770 | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 1.92 | monomer | 1 x LJA, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rl6.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rl6.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rl6.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rl6.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rl6.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlc.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z56923284 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 1.92 | monomer | 1 x VVM, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlc.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlc.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlc.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlc.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlc.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rm9.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z2856434942 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.08 | monomer | 1 x EJQ, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rm9.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rm9.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rm9.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rm9.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rm9.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rm4.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1639162606 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.96 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rm4.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rm4.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rm4.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rm4.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rm4.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rl9.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1703168683 | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 1.79 | monomer | 1 x UR7, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rl9.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rl9.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rl9.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rl9.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rl9.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rmb.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z2856434920 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.21 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rmb.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rmb.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rmb.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rmb.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rmb.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rmc.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z24758179 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.15 | monomer | 1 x 6SU, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rmc.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rmc.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rmc.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rmc.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rmc.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rmf.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z54226006 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.23 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rmf.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rmf.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rmf.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rmf.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rmf.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rmj.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z68299550 | 0.16 | | 11.27 | 0.62 | 24-299 | X-ray | 2.10 | monomer | 1 x JOV, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rmj.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rmj.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rmj.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rmj.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rmj.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rm1.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z426041412 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 1.90 | monomer | 1 x RY4, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rm1.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rm1.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rm1.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rm1.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rm1.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rmm.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with POB0066 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.20 | monomer | 1 x VXG, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rmm.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rmm.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rmm.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rmm.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rmm.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlh.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z2856434778 | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 2.38 | monomer | 1 x K2P, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlh.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlh.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlh.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlh.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlh.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlq.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z285782452 | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 2.23 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlq.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlq.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlq.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlq.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlq.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlj.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1407673036 | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 1.88 | monomer | 1 x VW4, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlj.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlj.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlj.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlj.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlj.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlf.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z235341991 | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 2.24 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlf.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlf.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlf.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlf.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlf.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rl8.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z53825177 | 0.16 | | 11.27 | 0.62 | 24-299 | X-ray | 2.21 | monomer | 2 x VVG, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rl8.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rl8.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rl8.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rl8.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rl8.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rm0.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1492796719 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 1.91 | monomer | 1 x S7G, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rm0.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rm0.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rm0.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rm0.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rm0.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlt.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z53116498 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.43 | monomer | 1 x UVJ, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlt.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlt.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlt.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlt.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlt.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rln.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z364328788 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.15 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rln.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rln.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rln.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rln.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rln.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rl7.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z364321922 | 0.16 | | 11.27 | 0.62 | 24-299 | X-ray | 1.89 | monomer | 1 x VVD, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rl7.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rl7.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rl7.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rl7.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rl7.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlb.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z216450634 | 0.16 | | 11.27 | 0.62 | 24-299 | X-ray | 1.98 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlb.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlb.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlb.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlb.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlb.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlv.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z2467208649 | 0.16 | | 11.27 | 0.62 | 24-299 | X-ray | 2.21 | monomer | 1 x VWJ, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlv.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlv.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlv.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlv.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlv.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlz.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z2293643386 | 0.16 | | 11.27 | 0.62 | 24-299 | X-ray | 1.97 | monomer | 1 x VWM, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlz.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlz.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlz.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlz.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlz.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rmd.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z57614330 | 0.16 | | 11.27 | 0.62 | 24-299 | X-ray | 1.92 | monomer | 1 x VWY, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rmd.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rmd.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rmd.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rmd.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rmd.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rll.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z425387594 | 0.16 | | 11.27 | 0.62 | 24-299 | X-ray | 2.08 | monomer | 1 x H04, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rll.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rll.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rll.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rll.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rll.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlo.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1454310449 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.10 | monomer | 1 x UQS, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlo.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlo.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlo.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlo.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlo.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rm5.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z373768900 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.06 | monomer | 1 x NUA, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rm5.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rm5.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rm5.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rm5.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rm5.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rm6.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z396380540 | 0.19 | | 11.27 | 0.62 | 24-299 | X-ray | 2.13 | monomer | 1 x HR5, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rm6.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rm6.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rm6.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rm6.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rm6.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rmh.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1101755952 | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 2.02 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rmh.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rmh.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rmh.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rmh.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rmh.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rli.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z45617795 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.26 | monomer | 2 x JFM, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rli.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rli.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rli.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rli.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rli.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rmk.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1273312153 | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 2.08 | monomer | 1 x O2A, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rmk.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rmk.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rmk.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rmk.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rmk.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlu.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z744754722 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.35 | monomer | 1 x JG4, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlu.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlu.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlu.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlu.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlu.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rme.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z26333434 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.23 | monomer | 1 x RYM, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rme.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rme.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rme.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rme.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rme.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rls.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z59181945 | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 2.28 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rls.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rls.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rls.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rls.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rls.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rml.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z85956652 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.43 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rml.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rml.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rml.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rml.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rml.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rly.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z2027049478 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.43 | monomer | 2 x K34, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rly.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rly.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rly.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rly.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rly.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlr.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z822382694 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.32 | monomer | 1 x VWD, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlr.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlr.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlr.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlr.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlr.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rm3.1.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1745658474 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.09 | monomer | 1 x S7J, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rm3.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rm3.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rm3.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rm3.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rm3.1 TLVPQEHYVRITG-----------------------------------------------
|
| 5rm2.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1741964527 | 0.16 | | 11.27 | 0.62 | 24-299 | X-ray | 1.82 | monomer | 2 x UXG, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rm2.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rm2.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rm2.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rm2.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rm2.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rma.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z321318226 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 1.89 | monomer | 1 x JHJ, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rma.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rma.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rma.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rma.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rma.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rlm.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1650168321 | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 1.86 | monomer | 1 x VW7, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rlm.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rlm.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rlm.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rlm.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rlm.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rmg.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z285675722 | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 2.12 | monomer | 1 x MUK, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rmg.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rmg.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rmg.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rmg.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rmg.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rmi.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z53860899 | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 2.12 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rmi.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rmi.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rmi.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rmi.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rmi.2 TLVPQEHYVRITG-----------------------------------------------
|
| 5rle.2.A | Helicase
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1429867185 | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 2.27 | monomer | 1 x VVP, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 5rle.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 5rle.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 5rle.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 5rle.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5rle.2 TLVPQEHYVRITG-----------------------------------------------
|
| 7cxm.1.H | Helicase
Architecture of a SARS-CoV-2 mini replication and transcription complex | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 1 x U-A-A-A-A-U | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7cxm.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7cxm.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7cxm.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7cxm.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7cxm.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7cxn.1.G | Helicase
Architecture of a SARS-CoV-2 mini replication and transcription complex | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 1 x U-A-A-A-A-U | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7cxn.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7cxn.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7cxn.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7cxn.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7cxn.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7cxm.1.G | Helicase
Architecture of a SARS-CoV-2 mini replication and transcription complex | 0.18 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 1 x U-A-A-A-A-U | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7cxm.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7cxm.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7cxm.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7cxm.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7cxm.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7cyq.1.H | Helicase
Cryo-EM structure of an extended SARS-CoV-2 replication and transcription complex reveals an intermediate state in cap synthesis | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GDP, 1 x MG | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7cyq.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7cyq.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7cyq.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7cyq.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7cyq.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7cyq.1.G | Helicase
Cryo-EM structure of an extended SARS-CoV-2 replication and transcription complex reveals an intermediate state in cap synthesis | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GDP, 1 x MG | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7cyq.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7cyq.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7cyq.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7cyq.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7cyq.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7cxn.1.H | Helicase
Architecture of a SARS-CoV-2 mini replication and transcription complex | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 1 x U-A-A-A-A-U | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7cxn.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7cxn.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7cxn.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7cxn.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7cxn.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7egq.1.E | Helicase
Co-transcriptional capping machineries in SARS-CoV-2 RTC: Coupling of N7-methyltransferase and 3'-5' exoribonuclease with polymerase reveals mechanisms for capping and proofreading | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-2-4-2-4-2-2-… | 26 x ZN, 3 x MG | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7egq.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7egq.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7egq.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7egq.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7egq.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7egq.1.Q | Helicase
Co-transcriptional capping machineries in SARS-CoV-2 RTC: Coupling of N7-methyltransferase and 3'-5' exoribonuclease with polymerase reveals mechanisms for capping and proofreading | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-2-4-2-4-2-2-… | 26 x ZN, 3 x MG | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7egq.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7egq.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7egq.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7egq.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7egq.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7egq.1.R | Helicase
Co-transcriptional capping machineries in SARS-CoV-2 RTC: Coupling of N7-methyltransferase and 3'-5' exoribonuclease with polymerase reveals mechanisms for capping and proofreading | 0.20 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-2-4-2-4-2-2-… | 26 x ZN, 3 x MG | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7egq.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7egq.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7egq.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7egq.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7egq.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7egq.1.M | Helicase
Co-transcriptional capping machineries in SARS-CoV-2 RTC: Coupling of N7-methyltransferase and 3'-5' exoribonuclease with polymerase reveals mechanisms for capping and proofreading | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-2-4-2-4-2-2-… | 26 x ZN, 3 x MG | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7egq.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7egq.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7egq.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7egq.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7egq.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7eiz.1.J | Helicase
Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-1-1-1-… | 13 x ZN, 1 x MG | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7eiz.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7eiz.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7eiz.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7eiz.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7eiz.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7eiz.1.K | Helicase
Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-1-1-1-… | 13 x ZN, 1 x MG | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7eiz.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7eiz.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7eiz.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7eiz.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7eiz.1 TLVPQEHYVRITG-----------------------------------------------
|
| 8gwo.1.H | Helicase
A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GNP | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 8gwo.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 8gwo.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 8gwo.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 8gwo.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 8gwo.1 TLVPQEHYVRITG-----------------------------------------------
|
| 8gwb.1.H | Helicase
A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 2 x MN, 1 x A-U | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 8gwb.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 8gwb.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 8gwb.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 8gwb.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 8gwb.1 TLVPQEHYVRITG-----------------------------------------------
|
| 8gwo.1.G | Helicase
A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GNP | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 8gwo.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 8gwo.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 8gwo.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 8gwo.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 8gwo.1 TLVPQEHYVRITG-----------------------------------------------
|
| 8gwb.1.G | Helicase
A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.20 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 2 x MN, 1 x A-U | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 8gwb.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 8gwb.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 8gwb.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 8gwb.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 8gwb.1 TLVPQEHYVRITG-----------------------------------------------
|
| 8gwi.1.H | Helicase
A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.20 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GTP | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 8gwi.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 8gwi.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 8gwi.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 8gwi.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 8gwi.1 TLVPQEHYVRITG-----------------------------------------------
|
| 8gwg.1.H | Helicase
A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.20 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GTP | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 8gwg.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 8gwg.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 8gwg.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 8gwg.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 8gwg.1 TLVPQEHYVRITG-----------------------------------------------
|
| 8gwf.1.H | Helicase
A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.20 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GTP | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 8gwf.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 8gwf.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 8gwf.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 8gwf.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 8gwf.1 TLVPQEHYVRITG-----------------------------------------------
|
| 8gwe.1.H | Helicase
A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.20 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GNP, 1 x MG, 1 x A-U-U-A | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 8gwe.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 8gwe.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 8gwe.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 8gwe.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 8gwe.1 TLVPQEHYVRITG-----------------------------------------------
|
| 8gwi.1.G | Helicase
A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GTP | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 8gwi.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 8gwi.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 8gwi.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 8gwi.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 8gwi.1 TLVPQEHYVRITG-----------------------------------------------
|
| 8gwg.1.G | Helicase
A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GTP | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 8gwg.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 8gwg.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 8gwg.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 8gwg.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 8gwg.1 TLVPQEHYVRITG-----------------------------------------------
|
| 8gwf.1.G | Helicase
A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GTP | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 8gwf.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 8gwf.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 8gwf.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 8gwf.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 8gwf.1 TLVPQEHYVRITG-----------------------------------------------
|
| 8gwe.1.G | Helicase
A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GNP, 1 x MG, 1 x A-U-U-A | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 8gwe.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 8gwe.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 8gwe.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 8gwe.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 8gwe.1 TLVPQEHYVRITG-----------------------------------------------
|
| 8gwn.1.H | Helicase
A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GNP | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 8gwn.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 8gwn.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 8gwn.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 8gwn.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 8gwn.1 TLVPQEHYVRITG-----------------------------------------------
|
| 8gwn.1.G | Helicase
A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.17 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GNP | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 8gwn.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 8gwn.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 8gwn.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 8gwn.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 8gwn.1 TLVPQEHYVRITG-----------------------------------------------
|
| 6jyt.1.A | Helicase
Delicate structural coordination of the Severe Acute Respiratory Syndrome coronavirus Nsp13 upon ATP hydrolysis | 0.19 | | 11.27 | 0.62 | 24-299 | X-ray | 2.80 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 6jyt.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 6jyt.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 6jyt.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 6jyt.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 6jyt.1 TLVPQEHYVRITG-----------------------------------------------
|
| 6jyt.2.A | Helicase
Delicate structural coordination of the Severe Acute Respiratory Syndrome coronavirus Nsp13 upon ATP hydrolysis | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 2.80 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 6jyt.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 6jyt.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 6jyt.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 6jyt.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 6jyt.2 TLVPQEHYVRITG-----------------------------------------------
|
| 7nio.1.B | SARS-CoV-2 helicase NSP13
Crystal structure of the SARS-CoV-2 helicase APO form | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 2.20 | homo-dimer | 6 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7nio.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7nio.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7nio.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7nio.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7nio.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7nio.1.A | SARS-CoV-2 helicase NSP13
Crystal structure of the SARS-CoV-2 helicase APO form | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 2.20 | homo-dimer | 6 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7nio.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7nio.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7nio.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7nio.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7nio.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7nn0.3.A | SARS-CoV-2 helicase NSP13
Crystal structure of the SARS-CoV-2 helicase in complex with AMP-PNP | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 3.04 | monomer | 3 x ZN, 1 x ANP | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7nn0.3 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7nn0.3 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7nn0.3 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7nn0.3 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7nn0.3 TLVPQEHYVRITG-----------------------------------------------
|
| 7nn0.1.A | SARS-CoV-2 helicase NSP13
Crystal structure of the SARS-CoV-2 helicase in complex with AMP-PNP | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 3.04 | monomer | 1 x ANP, 3 x ZN, 1 x MG | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7nn0.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7nn0.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7nn0.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7nn0.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7nn0.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7nn0.4.A | SARS-CoV-2 helicase NSP13
Crystal structure of the SARS-CoV-2 helicase in complex with AMP-PNP | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 3.04 | monomer | 3 x ZN, 1 x ANP | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7nn0.4 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7nn0.4 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7nn0.4 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7nn0.4 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7nn0.4 TLVPQEHYVRITG-----------------------------------------------
|
| 6zsl.1.A | SARS-CoV-2 helicase NSP13
Crystal structure of the SARS-CoV-2 helicase at 1.94 Angstrom resolution | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 1.94 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 6zsl.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 6zsl.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 6zsl.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 6zsl.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 6zsl.1 TLVPQEHYVRITG-----------------------------------------------
|
| 6zsl.2.A | SARS-CoV-2 helicase NSP13
Crystal structure of the SARS-CoV-2 helicase at 1.94 Angstrom resolution | 0.17 | | 11.27 | 0.62 | 24-299 | X-ray | 1.94 | monomer | 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 6zsl.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 6zsl.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 6zsl.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 6zsl.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 6zsl.2 TLVPQEHYVRITG-----------------------------------------------
|
| 7nn0.2.A | SARS-CoV-2 helicase NSP13
Crystal structure of the SARS-CoV-2 helicase in complex with AMP-PNP | 0.18 | | 11.27 | 0.62 | 24-299 | X-ray | 3.04 | monomer | 1 x ANP, 3 x ZN | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7nn0.2 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7nn0.2 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7nn0.2 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7nn0.2 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7nn0.2 TLVPQEHYVRITG-----------------------------------------------
|
| 7kro.1.F | Helicase
Structure of SARS-CoV-2 backtracked complex complex bound to nsp13 helicase - nsp13(2)-BTC | 0.20 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 3 x MG, 3 x ADP, 3 x 1N7, 2 x AF3 | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7kro.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7kro.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7kro.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7kro.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7kro.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7kro.1.E | Helicase
Structure of SARS-CoV-2 backtracked complex complex bound to nsp13 helicase - nsp13(2)-BTC | 0.20 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 3 x MG, 3 x ADP, 3 x 1N7, 2 x AF3 | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7kro.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7kro.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7kro.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7kro.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7kro.1 TLVPQEHYVRITG-----------------------------------------------
|
| 6xez.1.E | Helicase
Structure of SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC | 0.20 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 3 x MG, 3 x ADP, 3 x 1N7, 2 x AF3 | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 6xez.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 6xez.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 6xez.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 6xez.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 6xez.1 TLVPQEHYVRITG-----------------------------------------------
|
| 6xez.1.F | Helicase
Structure of SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC | 0.20 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 3 x MG, 3 x ADP, 3 x 1N7, 2 x AF3 | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 6xez.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 6xez.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 6xez.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 6xez.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 6xez.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7krn.1.E | Helicase
Structure of SARS-CoV-2 backtracked complex bound to nsp13 helicase - nsp13(1)-BTC | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-1-mer | 5 x ZN, 2 x MG, 2 x ADP, 3 x 1N7, 1 x AF3 | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7krn.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7krn.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7krn.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7krn.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7krn.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7re1.1.F | Helicase
SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC (composite) | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 3 x MG, 3 x ADP, 3 x 1N7, 2 x AF3 | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7re1.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7re1.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7re1.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7re1.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7re1.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7rdz.1.E | Helicase
SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC - apo class | 0.20 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 1 x MG, 1 x ADP | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7rdz.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7rdz.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7rdz.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7rdz.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7rdz.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7re3.1.N | Helicase
SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC dimer | 0.20 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-2-4-2-4-mer | 16 x ZN, 6 x MG, 6 x ADP, 4 x AF3, 2 x 1N7 | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7re3.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7re3.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7re3.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7re3.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7re3.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7re3.1.F | Helicase
SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC dimer | 0.20 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-2-4-2-4-mer | 16 x ZN, 6 x MG, 6 x ADP, 4 x AF3, 2 x 1N7 | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7re3.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7re3.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7re3.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7re3.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7re3.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7re0.1.E | Helicase
SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC - swiveled class | 0.20 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 3 x MG, 3 x ADP, 2 x AF3 | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7re0.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7re0.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7re0.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7re0.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7re0.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7rdy.1.F | Helicase
SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC - engaged class | 0.20 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 3 x MG, 3 x ADP, 3 x 1N7, 2 x AF3 | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7rdy.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7rdy.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7rdy.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7rdy.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7rdy.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7re3.1.M | Helicase
SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC dimer | 0.20 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-2-4-2-4-mer | 16 x ZN, 6 x MG, 6 x ADP, 4 x AF3, 2 x 1N7 | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7re3.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7re3.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7re3.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7re3.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7re3.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7re3.1.E | Helicase
SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC dimer | 0.20 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-2-4-2-4-mer | 16 x ZN, 6 x MG, 6 x ADP, 4 x AF3, 2 x 1N7 | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7re3.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7re3.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7re3.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7re3.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7re3.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7re2.1.E | Helicase
SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(1)-RTC | 0.20 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-1-mer | 5 x ZN, 2 x MG, 2 x ADP, 3 x 1N7, 1 x AF3 | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7re2.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7re2.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7re2.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7re2.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7re2.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7rdy.1.E | Helicase
SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC - engaged class | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 3 x MG, 3 x ADP, 3 x 1N7, 2 x AF3 | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7rdy.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7rdy.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7rdy.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7rdy.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7rdy.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7rdz.1.F | Helicase
SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC - apo class | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 1 x MG, 1 x ADP | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7rdz.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7rdz.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7rdz.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7rdz.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7rdz.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7re1.1.E | Helicase
SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC (composite) | 0.20 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 3 x MG, 3 x ADP, 3 x 1N7, 2 x AF3 | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7re1.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7re1.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7re1.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7re1.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7re1.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7rdx.1.E | Helicase
SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC - open class | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 3 x MG, 3 x ADP, 3 x 1N7, 2 x AF3 | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7rdx.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7rdx.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7rdx.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7rdx.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7rdx.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7re0.1.F | Helicase
SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC - swiveled class | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 3 x MG, 3 x ADP, 2 x AF3 | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7re0.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7re0.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7re0.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7re0.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7re0.1 TLVPQEHYVRITG-----------------------------------------------
|
| 7rdx.1.F | Helicase
SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC - open class | 0.19 | | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 3 x MG, 3 x ADP, 3 x 1N7, 2 x AF3 | HHblits | 0.25 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG 7rdx.1 -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD
target VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------ 7rdx.1 VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI
target --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM 7rdx.1 LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL
target EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG 7rdx.1 NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP
target SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 7rdx.1 TLVPQEHYVRITG-----------------------------------------------
|
| 8g6r.1.A | nsp12
Porcine epidemic diarrhea virus core polymerase complex | 0.15 | | 7.48 | 0.62 | 22-325 | EM | 0.00 | hetero-1-1-1-mer | 2 x ZN | HHblits | 0.24 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNT-----VYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNL 8g6r.1 ---------------------IVGVVTLDNQDLNGDFYDFGDFTCSIKGMGIPICTS--YYSYMMPVMGMTN--CLASEC
target GVDIA-------------------------ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQ 8g6r.1 FVKSDIFGEDFKSYDLLEYDFTEHKTALFNKYFKYWGLQYHPNCVDCSDEQCIVH--------------CANFNTLFSTT
target VDLFRNARN------------------------------------------GVLITEGSVK----------GLQPS---V 8g6r.1 IPITAFGPLCRKCWIDGVPLVTTAGYHFKQLGIVWNNDLNLHSSRLSINELLQFCSDPALLIASSPALVDQRTVCFSVAA
target GPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHI 8g6r.1 -LGTGMTNQT-VKPGHFNKEFYDFLLE--------QGFFSEGSEL-------TLKHFFFAQK-----GDAAVKDFDYY--
target VYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVS 8g6r.1 RYNRPT-------VLDICQARVVY-----------------------------QIVQRYFDIYEGGCIT-----------
target KVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 8g6r.1 -AKEVVVTNL---------------------
|
| 5f17.1.A | Non-structural protein 11
Structure of EAV NSP11 K170A mutant at 3.19A | 0.29 | | 22.86 | 0.51 | 135-344 | X-ray | 3.20 | homo-dimer | | HHblits | 0.32 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5f17.1 --------------------------------------------------------------------------------
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5f17.1 ------------------------------------------------------DRYPNCLQITLQQVCELSKPC--SAG
target SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRS-QMEIDFLELAMDEFIERYKLEGYAFEHIVYG 5f17.1 YMVGQSVFVQTPGVTSYWLTEWVDGKARALPDSLFSSGRFETNSRAFLDEAEEKFAA---------------AHPHACLG
target DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV 5f17.1 EINKSTVGGSHFIFSQYLPPL---------LPA-DAVALVGAS-LAGKAAAAACSVVDVYAPSFEPYLHP---ETLSRVY
target KVTIDYTEISFMLWCKDGHVETFYPKLQ 5f17.1 KIMIDFKPCRLMVWRNA----TFYVQ--
|
| 5f17.1.B | Non-structural protein 11
Structure of EAV NSP11 K170A mutant at 3.19A | 0.25 | | 22.86 | 0.51 | 135-344 | X-ray | 3.20 | homo-dimer | | HHblits | 0.32 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5f17.1 --------------------------------------------------------------------------------
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5f17.1 ------------------------------------------------------DRYPNCLQITLQQVCELSKPC--SAG
target SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRS-QMEIDFLELAMDEFIERYKLEGYAFEHIVYG 5f17.1 YMVGQSVFVQTPGVTSYWLTEWVDGKARALPDSLFSSGRFETNSRAFLDEAEEKFAA---------------AHPHACLG
target DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV 5f17.1 EINKSTVGGSHFIFSQYLPPL---------LPA-DAVALVGAS-LAGKAAAAACSVVDVYAPSFEPYLHP---ETLSRVY
target KVTIDYTEISFMLWCKDGHVETFYPKLQ 5f17.1 KIMIDFKPCRLMVWRNA----TFYVQ--
|
| 5eyi.1.A | Non-structural protein 11
Structure of PRRSV apo-NSP11 at 2.16A | 0.29 | | 19.10 | 0.51 | 135-346 | X-ray | 2.16 | homo-dimer | | HHblits | 0.30 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5eyi.1 --------------------------------------------------------------------------------
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5eyi.1 ------------------------------------------------------EKWPDRLVASLRPIHKYSRAC-IGAG
target SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRS-QMEIDFLELAMDEFIERYKLEGYAFEHIVYG 5eyi.1 YMVGPSVFLGTPGVVSYYLTKFVKGEAQLLPETVFSTGRIEVDCREYLDDREREVAA---------------SLPHAFIG
target DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV 5eyi.1 DVKGTTVGGCHHVTSRYLPRVL---PKE-------SVAVVGVS-SPGKAAAALCTLTDVYLPDLEAYLHP---ETQSKCW
target KVTIDYTEISFMLWCKDGHVETFYPKLQ 5eyi.1 KMMLDFKEVRLMVWRDK----TAYFQLE
|
| 5eyi.1.B | Non-structural protein 11
Structure of PRRSV apo-NSP11 at 2.16A | 0.25 | | 19.10 | 0.51 | 135-346 | X-ray | 2.16 | homo-dimer | | HHblits | 0.30 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5eyi.1 --------------------------------------------------------------------------------
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5eyi.1 ------------------------------------------------------EKWPDRLVASLRPIHKYSRAC-IGAG
target SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRS-QMEIDFLELAMDEFIERYKLEGYAFEHIVYG 5eyi.1 YMVGPSVFLGTPGVVSYYLTKFVKGEAQLLPETVFSTGRIEVDCREYLDDREREVAA---------------SLPHAFIG
target DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV 5eyi.1 DVKGTTVGGCHHVTSRYLPRVL---PKE-------SVAVVGVS-SPGKAAAALCTLTDVYLPDLEAYLHP---ETQSKCW
target KVTIDYTEISFMLWCKDGHVETFYPKLQ 5eyi.1 KMMLDFKEVRLMVWRDK----TAYFQLE
|
| 5hbz.1.A | Non-structural protein 11
Structure of EAV NSP11 K170A mutant at 3.10A | 0.28 | | 22.99 | 0.50 | 136-344 | X-ray | 3.10 | homo-dimer | | HHblits | 0.32 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5hbz.1 --------------------------------------------------------------------------------
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5hbz.1 -------------------------------------------------------RYPNCLQITLQQVCELSKPC--SAG
target SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRS-QMEIDFLELAMDEFIERYKLEGYAFEHIVYG 5hbz.1 YMVGQSVFVQTPGVTSYWLTEWVDGKARALPDSLFSSGRFETNSRAFLDEAEEKFAA---------------AHPHACLG
target DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV 5hbz.1 EINKSTVGGSHFIFSQYLPPL---------LPA-DAVALVGAS-LAGKAAAAACSVVDVYAPSFEPYLHP---ETLSRVY
target KVTIDYTEISFMLWCKDGHVETFYPKLQ 5hbz.1 KIMIDFKPCRLMVWRNA----TFYVQ--
|
| 5hbz.1.B | Non-structural protein 11
Structure of EAV NSP11 K170A mutant at 3.10A | 0.24 | | 22.99 | 0.50 | 136-344 | X-ray | 3.10 | homo-dimer | | HHblits | 0.32 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5hbz.1 --------------------------------------------------------------------------------
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5hbz.1 -------------------------------------------------------RYPNCLQITLQQVCELSKPC--SAG
target SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRS-QMEIDFLELAMDEFIERYKLEGYAFEHIVYG 5hbz.1 YMVGQSVFVQTPGVTSYWLTEWVDGKARALPDSLFSSGRFETNSRAFLDEAEEKFAA---------------AHPHACLG
target DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV 5hbz.1 EINKSTVGGSHFIFSQYLPPL---------LPA-DAVALVGAS-LAGKAAAAACSVVDVYAPSFEPYLHP---ETLSRVY
target KVTIDYTEISFMLWCKDGHVETFYPKLQ 5hbz.1 KIMIDFKPCRLMVWRNA----TFYVQ--
|
| 5hc1.1.A | Non-structural protein 11
Structure of EAV NSP11 H141A mutant at 3.10A | 0.27 | | 22.29 | 0.51 | 135-344 | X-ray | 3.10 | homo-dimer | | HHblits | 0.31 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5hc1.1 --------------------------------------------------------------------------------
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5hc1.1 ------------------------------------------------------DRYPNCLQITLQQVCELSKPC--SAG
target SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRS-QMEIDFLELAMDEFIERYKLEGYAFEHIVYG 5hc1.1 YMVGQSVFVQTPGVTSYWLTEWVDGKARALPDSLFSSGRFETNSRAFLDEAEEKFAA---------------AHPHACLG
target DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV 5hc1.1 EINKSTVGGSAFIFSQYLPPLL---PA-------DAVALVGAS-LAGKAAKAACSVVDVYAPSFEPYLHP---ETLSRVY
target KVTIDYTEISFMLWCKDGHVETFYPKLQ 5hc1.1 KIMIDFKPCRLMVWRNA----TFYVQ--
|
| 5hc1.1.B | Non-structural protein 11
Structure of EAV NSP11 H141A mutant at 3.10A | 0.27 | | 22.29 | 0.51 | 135-344 | X-ray | 3.10 | homo-dimer | | HHblits | 0.31 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5hc1.1 --------------------------------------------------------------------------------
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5hc1.1 ------------------------------------------------------DRYPNCLQITLQQVCELSKPC--SAG
target SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRS-QMEIDFLELAMDEFIERYKLEGYAFEHIVYG 5hc1.1 YMVGQSVFVQTPGVTSYWLTEWVDGKARALPDSLFSSGRFETNSRAFLDEAEEKFAA---------------AHPHACLG
target DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV 5hc1.1 EINKSTVGGSAFIFSQYLPPLL---PA-------DAVALVGAS-LAGKAAKAACSVVDVYAPSFEPYLHP---ETLSRVY
target KVTIDYTEISFMLWCKDGHVETFYPKLQ 5hc1.1 KIMIDFKPCRLMVWRNA----TFYVQ--
|
| 5hc1.2.A | Non-structural protein 11
Structure of EAV NSP11 H141A mutant at 3.10A | 0.26 | | 22.29 | 0.51 | 135-344 | X-ray | 3.10 | homo-dimer | | HHblits | 0.31 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5hc1.2 --------------------------------------------------------------------------------
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5hc1.2 ------------------------------------------------------DRYPNCLQITLQQVCELSKPC--SAG
target SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRS-QMEIDFLELAMDEFIERYKLEGYAFEHIVYG 5hc1.2 YMVGQSVFVQTPGVTSYWLTEWVDGKARALPDSLFSSGRFETNSRAFLDEAEEKFAA---------------AHPHACLG
target DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV 5hc1.2 EINKSTVGGSAFIFSQYLPPLL---PA-------DAVALVGAS-LAGKAAKAACSVVDVYAPSFEPYLHP---ETLSRVY
target KVTIDYTEISFMLWCKDGHVETFYPKLQ 5hc1.2 KIMIDFKPCRLMVWRNA----TFYVQ--
|
| 5hc1.2.B | Non-structural protein 11
Structure of EAV NSP11 H141A mutant at 3.10A | 0.25 | | 22.29 | 0.51 | 135-344 | X-ray | 3.10 | homo-dimer | | HHblits | 0.31 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5hc1.2 --------------------------------------------------------------------------------
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5hc1.2 ------------------------------------------------------DRYPNCLQITLQQVCELSKPC--SAG
target SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRS-QMEIDFLELAMDEFIERYKLEGYAFEHIVYG 5hc1.2 YMVGQSVFVQTPGVTSYWLTEWVDGKARALPDSLFSSGRFETNSRAFLDEAEEKFAA---------------AHPHACLG
target DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV 5hc1.2 EINKSTVGGSAFIFSQYLPPLL---PA-------DAVALVGAS-LAGKAAKAACSVVDVYAPSFEPYLHP---ETLSRVY
target KVTIDYTEISFMLWCKDGHVETFYPKLQ 5hc1.2 KIMIDFKPCRLMVWRNA----TFYVQ--
|
| 5da1.1.A | endoribonuclease
A Dimerization-Dependent Mechanism Drives PRRSV NSP11 Functions As a Beta Interferon Antagonist and Endoribonuclease | 0.27 | | 19.21 | 0.51 | 135-341 | X-ray | 2.75 | homo-dimer | | HHblits | 0.30 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5da1.1 --------------------------------------------------------------------------------
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5da1.1 ------------------------------------------------------ERWPDRLVASLRPIHKYSRAC-IGAG
target SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRS-QMEIDFLELAMDEFIERYKLEGYAFEHIVYG 5da1.1 YMVGPSVFLGTPGVVSYYLTKFVRGEAQVLPETVFSTGRIEVDCREYLDDRERVVAE---------------SLPHAFIG
target DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV 5da1.1 DVKGTTVGGCHHVTSKYLPRFL---PKE-------SVAVVGV-SSPGKAAKAVCTLTDVYLPDLEAYLHPE---TQSRCW
target KVTIDYTEISFMLWCKDGHVETFYPKLQ 5da1.1 KVMLDFKEVRLMVWKDKTAYFQL-----
|
| 5da1.1.B | endoribonuclease
A Dimerization-Dependent Mechanism Drives PRRSV NSP11 Functions As a Beta Interferon Antagonist and Endoribonuclease | 0.25 | | 19.21 | 0.51 | 135-341 | X-ray | 2.75 | homo-dimer | | HHblits | 0.30 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5da1.1 --------------------------------------------------------------------------------
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5da1.1 ------------------------------------------------------ERWPDRLVASLRPIHKYSRAC-IGAG
target SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRS-QMEIDFLELAMDEFIERYKLEGYAFEHIVYG 5da1.1 YMVGPSVFLGTPGVVSYYLTKFVRGEAQVLPETVFSTGRIEVDCREYLDDRERVVAE---------------SLPHAFIG
target DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV 5da1.1 DVKGTTVGGCHHVTSKYLPRFL---PKE-------SVAVVGV-SSPGKAAKAVCTLTDVYLPDLEAYLHPE---TQSRCW
target KVTIDYTEISFMLWCKDGHVETFYPKLQ 5da1.1 KVMLDFKEVRLMVWKDKTAYFQL-----
|
| 5da1.1.A | endoribonuclease
A Dimerization-Dependent Mechanism Drives PRRSV NSP11 Functions As a Beta Interferon Antagonist and Endoribonuclease | 0.17 | | 30.13 | 0.45 | 148-332 | X-ray | 2.75 | homo-dimer | | BLAST | 0.36 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5da1.1 --------------------------------------------------------------------------------
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5da1.1 -------------------------------------------------------------------VASLRPIHKYSRA
target SLNGVTLIGEAV----KTQFNYY--KKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEH 5da1.1 CIGAGYMVGPSVFLGTPGVVSYYLTKFVRGEAQVLPETVFSTGR----------IEVDCREYLDD----RERVVAESLPH
target IVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG-SSKCVCSVIDLLLDDFVEIIKSQDLSV 5da1.1 AFIGDVKGTTVGGCHHVTSKY---------LPRFLPKESVA---VVGVSSPGKAAKAVCTLTDVYLPDLEAYLHPE---T
target VSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5da1.1 QSRCWKVMLDFKEVRLMVW--------------
|
| 5da1.1.B | endoribonuclease
A Dimerization-Dependent Mechanism Drives PRRSV NSP11 Functions As a Beta Interferon Antagonist and Endoribonuclease | 0.15 | | 30.13 | 0.45 | 148-332 | X-ray | 2.75 | homo-dimer | | BLAST | 0.36 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 5da1.1 --------------------------------------------------------------------------------
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 5da1.1 -------------------------------------------------------------------VASLRPIHKYSRA
target SLNGVTLIGEAV----KTQFNYY--KKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEH 5da1.1 CIGAGYMVGPSVFLGTPGVVSYYLTKFVRGEAQVLPETVFSTGR----------IEVDCREYLDD----RERVVAESLPH
target IVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG-SSKCVCSVIDLLLDDFVEIIKSQDLSV 5da1.1 AFIGDVKGTTVGGCHHVTSKY---------LPRFLPKESVA---VVGVSSPGKAAKAVCTLTDVYLPDLEAYLHPE---T
target VSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ 5da1.1 QSRCWKVMLDFKEVRLMVW--------------
|
| 2c1w.1.A | ENDOU PROTEIN
THE STRUCTURE OF XENDOU: A SPLICING INDEPENDENT SNORNA PROCESSING ENDORIBONUCLEASE | 0.01 | | 19.05 | 0.12 | 228-269 | X-ray | 2.20 | monomer | | HHblits | 0.34 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 2c1w.1 --------------------------------------------------------------------------------
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 2c1w.1 --------------------------------------------------------------------------------
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 2c1w.1 -------------------------------------------------------------------DSCGFEHVFVGES
target SH-SQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVK 2c1w.1 KRGQEMMGLHNWVQFYLQEKRKNIDYKGYV--------------------------------------------------
target VTIDYTEISFMLWCKDGHVETFYPKLQ 2c1w.1 ---------------------------
|
| 2c1w.2.A | ENDOU PROTEIN
THE STRUCTURE OF XENDOU: A SPLICING INDEPENDENT SNORNA PROCESSING ENDORIBONUCLEASE | 0.01 | | 19.05 | 0.12 | 228-269 | X-ray | 2.20 | monomer | | HHblits | 0.34 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 2c1w.2 --------------------------------------------------------------------------------
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 2c1w.2 --------------------------------------------------------------------------------
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 2c1w.2 -------------------------------------------------------------------DSCGFEHVFVGES
target SH-SQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVK 2c1w.2 KRGQEMMGLHNWVQFYLQEKRKNIDYKGYV--------------------------------------------------
target VTIDYTEISFMLWCKDGHVETFYPKLQ 2c1w.2 ---------------------------
|
| 2c1w.3.A | ENDOU PROTEIN
THE STRUCTURE OF XENDOU: A SPLICING INDEPENDENT SNORNA PROCESSING ENDORIBONUCLEASE | 0.01 | | 19.05 | 0.12 | 228-269 | X-ray | 2.20 | monomer | | HHblits | 0.34 |
target SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA 2c1w.3 --------------------------------------------------------------------------------
target ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA 2c1w.3 --------------------------------------------------------------------------------
target SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF 2c1w.3 -------------------------------------------------------------------DSCGFEHVFVGES
target SH-SQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVK 2c1w.3 KRGQEMMGLHNWVQFYLQEKRKNIDYKGYV--------------------------------------------------
target VTIDYTEISFMLWCKDGHVETFYPKLQ 2c1w.3 ---------------------------
|